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The enzyme L-methionine γ-lyase (MGL) utilizes a pyridoxal-5’-phosphate-cofactor in order 
to convert L-methionine to α-ketobutyrate, ammonia and methyl mercaptan. MGL is 
proposed to be a potential drug target since it is expressed in the human pathogens, 
Trichomonas vaginalis and Entamoeba histolytica, but not in humans. There is currently a 
need to find alternative drug targets for these pathogens, because the misuse and overuse of 
the currently prescribed drugs of choice, metronidazole and tinidazole, have lead to drug 
resistance. 
The overall goal of this thesis was to examine the chemistry of MGL 1 from T. vaginalis 
(TvMGL1) by probing the active site by site-directed mutagenesis and with fluorinated 
methionine analogs. The mutation of the active site residue Cys113 to Ser led to a 5-fold 
decrease in turnover rate for L-methionine relative to the wild-type enzyme. The results 
suggest that the active site C113 residue plays an important role in catalysis and is consistent 
with literature reports for MGL homologs from Pseudomonas putida and E. histolytica. 
Probing the active site of TvMGL1 with the fluorinated methionine analogs, L-
difluoromethionine (DFM) and L-trifluoromethionine (TFM), were found to increase the 
turnover rate of the enzyme with an increase in fluorine substitution. The results suggest that 
the bulky fluorine atoms do not interfere with the Michaelis-Menten kinetics of the enzyme, 




The second goal of this thesis was to identify the reactive intermediates generated by the 
processing of TFM and the uninvestigated DFM by TvMGL1, and to investigate the 
theoretical and experimental chemistry and biochemistry of these fluorinated groups (CF3S- 
and CF2HS-). The reactivity of the intermediates, generated from the processing of DFM by 
TvMGL1 was correlated to the cytotoxicity observed in model organisms expressing 
TvMGL1, and consistent with the hypothesis that the intermediates will result in the 
thioformylation of primary amines. The results suggest that cytotoxicity requires 
thioacylation of a single primary amine, while sequential cross-linking of primary amines is 
not an absolute requirement. The relationship between the chemical structure of the reactive 
intermediates produced from the enzymatic processing of these analogs and their cellular 
toxicity is discussed. 
Attempts at the synthesis of 3,3-difluoro-O-methyl-L-homoserine were undertaken in order 
to examine the catalytic mechanism of TvMGL1, since the compound is expected to inhibit 
the enzyme. To ensure that the oxo moiety does not impede the chemistry of the enzyme, the 
analog, O-methyl-L-homoserine was examined as a potential substrate for TvMGL1. Several 
synthetic routes to 3,3-difluoro-O-methyl-L-homoserine were examined; however, attempts 
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CHAPTER 1  
BACKGROUND 
 
1.1. Authors’ Contributions 
Some of the material presented in this chapter was reproduced from Moya et al. (2009). The 
reproduced work includes section 1.3 (Epidemiology and Treatment for Parasitic Infections), 
section 1.8 (Cysteine Biosynthesis Pathways), Figure 1.11 and Figure 1.13. J. Honek wrote 
parts of section 1.3, and was revised by I. Moya. I. Moya wrote and revised section 1.8. 
 
1.2. Introduction 
L-Methionine γ-lyase (MGL) is a pyridoxal-5’-phosphate (PLP; 1.4)-dependent enzyme that 
is involved in the γ-elimination reaction of the thiomethyl group of L-methionine (1.2) and 
thiol group from its homologs, such as L-homocysteine (1.1) (Figure 1.1a) (Moya et al., 
2009). The enzyme is found in parasitic and anaerobic organisms, and is believed to play an 
important role in energy metabolism and L-cysteine biosynthesis by generating α-
ketobutyrate (1.3) from L-homocysteine derivatives, and hydrogen sulfide from L-
homocysteine, respectively (Figure 1.1a) (Westrop et al., 2006). MGL is also implicated in 
human pathogenicity, as reported for Porphyromonas gingivalis, in which the release of 
methanethiol from L-methionine and toxic hydrogen sulfide from L-homocysteine are 




potential drug target for treating anaerobic, parasitic infections since humans do not express 






Figure 1.1. Reaction overview for the catalysis of L-amino acids by the PLP-
dependent enzyme TvMGL1. 
a) Catalysis of L-homocysteine (1.1) and L-methionine (1.2) by TvMGL1 to produce 
α-ketobutyrate (1.3), ammonium and a mercaptan. b) Numbering system for 
pyridoxal-5’-phosphate (PLP; where R1 = OPO3
2-, 1.4), c) formation of an aldimine 
linkage between L-amino acid and PLP, d) the quinoid-aldimine intermediate 
generated from the first step in catalysis of the L-amino acid by the PLP-dependent 
enzyme, MGL 1 from T. vaginalis (TvMGL1-PLP; where R2 = Alkyl group). The 




1.3 1.1: X = H 




1.3. Epidemiology and Treatment for Parasitic Infections 
In humans, Trichomonas vaginalis is a flagellated, sexually transmitted protozoan that has an 
incidence rate of 5 million new cases per year in the United States (Schwebke, 2002). 
Infections result in vaginitis in women and urethritis in men; however, men are commonly 
asymptomatic (Schwebke, 2002). Entamoeba histolytica is a pseudopod protozoan that is 
associated with foodborne illnesses in regions with poor socioeconomic conditions and 
sanitation (Norhayati et al., 2003; Tarleton et al., 2006). Symptoms range from mild diarrhea 
to severe dysentery, and the infection results in 100,000 deaths annually worldwide (Ackers 
et al., 1997).  
The current treatment of these parasitic infections is the 5-nitroimidazole class of 
therapeutics, metronidazole (1.5) and tinidazole (1.6) that are approved by the FDA, while 
metronidazole is licensed for use in Canada (Figure 1.2) (Moya et al., 2009; Wendel and 
Workowski, 2007). The lack of alternative drugs for treating these infections is a particular 
concern, since there are emerging cases of metronidazole-resistant organisms, such as T. 
vaginalis and Clostridium difficile (Cudmore et al., 2004; Huang et al., 2009). In the latter 
case, Clostridium difficile, a Gram-positive bacterium is the leading cause of hospital-
acquired diarrhea which ranges from mild cases to severe pseudomembranous colitis (Huang 
et al., 2009). The number of outbreaks has increased since 2003 in part from the emerging 
hypervirulent C. difficile strains 027 and 078 (Bartlett et al., 1978; O'Connor et al., 2009). 




heteroresistance to metronidazole and other antimicrobial agents have been reported (Huang 
et al., 2009). Thus, there is a particular interest in identifying alternative drug targets in 
anaerobic human pathogens in order to avoid future outbreaks of metronidazole resistant 




Figure 1.2. Antiparasitic prodrugs metronidazole (1.5) and tinidazole (1.6). 
 
The metronidazole class of drugs, when activated by the anaerobic parasite, impairs the 
energy production of the pseudo-mitochondria, which is known as the mitosome in E. 
histolytica and the hydrosome in T. vaginalis (Tovar et al., 1999). Parasites derive their 
energy from catalyzing the oxidative decarboxylation of pyruvate to produce CO2 and acetyl-
Coenzyme A (CoA) by pyruvate:ferredoxin oxidoreductase (PFOR; Figure 1.3a) (Aguilera et 
al., 2008; Kulda, 1999). The two electrons generated from the oxidative decarboxylation of 
pyruvate are transferred to a [2Fe-2S] ferredoxin, a low molecular weight electron transport 
protein that has the potential to reduce a variety of cellular enzymes (Figure 1.3 a and c) 
(Crossnoe et al., 2002). The low redox potential of ferredoxin is reported to reduce 





1984). Activation of the drug is reported to cause breakage of DNA strands, possibly 





Figure 1.3. Energy metabolism and metronidazole drug target ferredoxin in T. 
vaginalis. 
a) Enzymes involved in energy metabolism within the hydrosome: NAD(P) malic 
enzyme (1), pyruvate:ferredoxin oxidoreductase (2) and hydrogenase (3). b) 
Activation of metronidazole by reduced ferredoxin. The figures were adapted from 
Kulda (1999). c) Crystal structure of ferredoxin from T. vaginalis with [2Fe-2S] 
cluster (brown and yellow, respectively; PDB 1L5P). The ribbon diagram for PDB 







Anaerobic parasitic resistance to the metronidazole class of prodrugs is classified into two 
categories 1) observed clinical resistance (termed in vivo resistance) and 2) laboratory 
generated resistance (termed in vitro resistance) (Dunne et al., 2003). In clinically resistant T. 
vaginalis isolates, the parasites have an increased susceptibility of intracellular oxygen than 
non-resistant strains, and a higher level of superoxide dismutase activity, but no significant 
reduction in the transcription levels of ferredoxin (Ellis et al., 1994; Rasoloson et al., 2001; 
Yarlett et al., 1986). The mechanism for the observed in vivo resistance is proposed to occur 
as follows: 1) metronidazole is reduced by ferredoxin, 2) reduced metronidazole is oxidized 
by oxygen to produce a superoxide radical, and 3) the superoxide radical is removed from the 
cell by superoxide dismutase (Figure 1.3b) (Rasoloson et al., 2001). Thus, in vivo resistance 
is proposed to occur by an increase intracellular concentration of oxygen as a result of a 
defective oxygen scavenging systems in the cytoplasm and hydrosome, which is likely to 
interfere with the mode of action for metronidazole (Rasoloson et al., 2001). For laboratory 
generated resistance in T. vaginalis, in vitro resistance, parasites are normally grown under 
anaerobic conditions with increasing concentrations of metro-nidazole over several months, 
resulting in a depleted hydrosomal activity (such as decrease in transcription levels for 
ferredoxin, PFOR, hydrogenase and malate enzyme) (Kulda et al., 1993; Tachezy et al., 
1993). Thus, the in vitro resistance model suggests that drug resistance is achieved as 




prodrug (Kulda, 1999). In general, there are discrepancies in the parasite’s mode of resistance 
between in vitro and in vivo metronidazole-resistant strains. 
Microaerophilic conditions with increasing concentrations of metronidazole are believed to 
accurately represent in vivo resistance for laboratory generated E. histolytica and T. vaginalis 
strains, because it is hypothesized that the model parasites exhibit an increase in superoxide 
dismutase activity, in order to neutralize the superoxide anions generated from the reduction 
of oxygen by the nitro radical (Rasoloson et al., 2001; Samarawickrema et al., 1997; 
Wassmann et al., 1999). Thus, the microaerophilic conditions for generating the 
metronidazole-resistant parasites are believed to mimic the elevated oxygen levels within the 
invaded tissue, and consequently reflect the mode of metronidazole resistance in clinical 
isolates (Rasoloson et al., 2001; Wassmann et al., 1999). On the other hand, metronidazole-
resistant parasites grown under anaerobic conditions, i.e., a depleted pseudo-mitochondrial 
activity, do not and will not survive in vivo because of their strict growth requirement for 
cysteine (Leitsch et al., 2009; Wassmann et al., 1999). 
In T. vaginalis and E. histolytica, cytosolic nitroreductase is reported to be a target for the 
activation of metronidazole, while inactivation is believed to occur in the pseudo-
mitochondria by nitroimidazole reductase (Pal et al., 2009). On the other hand, intracellular 
thioredoxin reductase is also implicated in the activation of metronidazole and other nitro 
compounds (Leitsch et al., 2009; Leitsch et al., 2007). Closer examination of T. vaginalis 




dinucleotide (FAD), an important cofactor for the activity of thioredoxin reductase, which is 
not observed in metronidazole sensitive strains (Leitsch et al., 2010). When these cells are 
supplemented with FAD, the clinical metronidazole resistant cell lines are susceptible to 
metronidazole (Leitsch et al., 2010). On the other hand, metronidazole sensitive T. vaginalis 
cell lines are found to become resistant to metronidazole when treated with 
diphenyleneiodonium ( an inhibitor of flavin-dependent enzymes), which is consistent with 
the biochemical features of metronidazole resistance in clinical isolates (Leitsch et al., 2010). 
Thus, thioredoxin reductase and possibly nitroreductase may potentially activate the 
metronidazole class of drugs as opposed to PFOR, and the decrease in thioredoxin reductase 
activity for the laboratory generated strains is consistent with metronidazole-resistance 
reported in clinical isolates (Leitsch et al., 2010). 
 
1.4. Potential Drug Target for Parasitic Infections 
An alternative, potential prodrug to metronidazole is L-trifluoromethionine (TFM), which is 
reported to be an effective compound against Trichomonas vaginalis, Entamoeba histolytica, 
Pseudomonas putida, Clostridium pasteurianum and Porphyromonas gingivalis (Coombs 
and Mottram, 2001; Tokoro et al., 2003; Yoshimura et al., 2002). The compound is activated 
by γ-eliminating enzymes, such as MGL (L-methionine-γ-lyase), which are expressed 
endogenously within the organism (Alston and Bright, 1983; Coombs and Mottram, 2001; 




lyase (CGL), the compound does not appear to be activated in mice since no cytotoxic side-
effects were observed over a period of 5 days when mice were injected with L-
trifluoromethionine (TFM; 4 μmol, 0.8 mg) (Yoshimura et al., 2002). 
The lack of cytotoxic effects in mammals may be explained by the very high Km value of 
mammalian CGL (48 mM) for TFM (Alston and Bright, 1983); and therefore, the enzyme 
does not readily activate the potential prodrug. This is surprising considering that the 
sequence identity is ~40% between parasitic protozoan MGL and human CGL (Table 1.1) 
(McKie et al., 1998; Tokoro et al., 2003). The structures for TvMGL1 (PDB 1E5F) and yeast 
CGL (PDB 1N8P) are remarkably similar, displaying an RMSD of ~2 Å (Table 1.1), with the 
exception that the binding pocket of CGL is more polar than MGL (Motoshima et al., 2000). 
Thus, this may explain why mice do not exhibit any noticeable cytotoxic side-effects when 
injected with TFM, while parasites expressing MGL are susceptible to the compound 
(Yoshimura et al., 2002). 
 
Table 1.1. Sequence and structural identity among MGL and PLP-dependent 
enzymes. 
Enzyme % Sequence identity relative 
to TvMGL1 
RMSD [Å] 
TPL (Citrobacter freundii) 13 3.2 
CGS (E. coli) 36 1.6 
CGL (Yeast) 42 1.7 
Sequence identity and structural similarity was calculated with DaliLite (Holm and Park, 2000). 




Bioactivity against MGL in E. histolytica and T. vaginalis may also extend to related 
enzymes found in anaerobic prokaryotes (Figure 1.4) (Carlton et al., 2007; Loftus et al., 
2005; Reeves, 1984; Rosenthal et al., 1997; Stanley, 2005). Analysis of the genome suggests 
that the genes for MGL (and other genes associated with fermentative metabolism) were 
acquired through a prokaryote to eukaryote gene transfer (Carlton et al., 2007; Loftus et al., 
2005). It is tempting to speculate that the anaerobic environment served as a selection 
pressure for protozoans to acquire genes from other anaerobic organisms, such that these 
organisms could better thrive in this environment (Andersson et al., 2006; Ochman et al., 
2000). For example, it is believed that glycolytic, catabolic and sulfur metabolic genes were 
acquired by lateral gene transfer in order to meet the organism’s energy demands (Carlton et 
al., 2007; Loftus et al., 2005) and to better tolerate oxidative molecular species. Thus, 
compounds that target MGL (or other enzymes related to fermentation) in anaerobic 
protozoan parasites may potentially target homologous MGL enzymes found in other 
anaerobic organisms (Figure 1.4), such as the drug resistant isolates of C. difficile (a gram-




Figure 1.4. Amino acid sequence alignment of MGL from various anaerobic organisms. 
The multiple sequence alignment of MGL from T. vaginalis (TvMGL1; GI: 15826191), E. histolytica (EhMGL1; 
GI:91522044), Citrobacter freundii (CfMGL; GI: 28883481), Psuedomonas putida (PpMGL1; GI: 21465428), 
Pyorphyromonas gingivalis (PgMGL; GI: 188995482), Clostridium difficile CIP 107932 (CdMGL; putative MGL; GI: 
255092847). Colour coding: Red, conserved; White and Grey, lower conservation; Blue, unconserved. Amino acid 
sequence alignment was generated with CLC Sequence Viewer v6.5.2 (CLC BIO, Toronto, ON). 
12 
 
1.5. Superfamilies of PLP-dependent Enzymes 
There are five evolutionarily unrelated superfamilies of PLP-dependent enzymes 
characterized to date (Grishin et al., 1995), which are classified as fold-type I to V (Figure 
1.5 a to e respectively) (Schneider et al., 2000). MGL belongs to the fold type I family, 
which are reported to catalyze a variety of PLP-dependent reactions such as elimination or 
replacement (at either α, β or γ positions), decarboxylation, and amino transfer (Figure 1.6). 
The chemistry for most of the superfamilies is essentially the same, except for fold-type V 
family, which appears to utilize the phosphate group of the cofactor for acid-base catalysis 
(Palm et al., 1990). The basic elements of PLP catalysis involve the covalent linkage of PLP 
to a lysine residue of the enzyme to form an internal aldimine (Figure 1.5f). This linkage 
occurs at the si-side, which interacts with the β-sheets and where deprotonation of Cα atom 
and protonation of C4’ atom occur in the active site of the enzyme (Christen et al., 1996; 
Ford et al., 1980). The binding of the L-amino acid substrate exchanges with the internal 
aldimine at the solvent exposed re-side of PLP to form the external aldimine (Figure 1.5g) 
(Christen and Mehta, 2001; Ford et al., 1980). The π bond established between the Cα atom 
of the amino acid and the substituent atom is aligned parallel with the π molecular orbital 
system of PLP. This allows for the π system of the cofactor to extend to the Cα atom, 







Figure 1.5. PLP-dependent enzymes fold types I to V, and the PLP cofactor 
displaying internal aldimine and external aldimine. 
PLP-dependent enzymes: a) fold type I (PDB 3QPG; Escherichia coli aspartate 
transaminase), b) fold type II (PDB 1D6S; Salmonella typhimurium O-acetylserine 
sulfhydrylase), c) fold type III (PDB 3S46, Streptococcus pneumonia alanine 
racemase), d) fold type IV (PDB 1DAA, Bacillus sphaericus D-amino acid 
aminotransferase) and e) fold type V (PDB 2AZD; E. coli maltodextrin 
phosphorylase). f) Lysine 256 side chain of the enzyme forming an internal aldimine 
at the si-side of the PLP cofactor (PDB 2EZ1; Citrobacter freundii TPL). g) L-
Methionine substrate (MET) forming an external aldimine at the re-side of the PLP 
cofactor (PDB 2VLH; C. freundii TPL). The images were rendered in Visual 










Figure 1.6. The reactions catalyzed by various PLP-dependent enzymes from fold 
type I family. 
a) Aspartate aminotransferase (AAT) catalyzes α-ketoglutarate (1.7) and L-aspartate 
(1.8) to L-glutamate (1.9) and oxaloacetate (1.10). b) 2,2-dialkylglycine 
decarboxylase (DGD) catalyzes pyruvate (1.11) and 2,2-dialkylglycine (1.12) to 
carbon dioxide, L-alanine (1.13) and acetone. c) Serine dehydratase (SDH) breaks 
down L-serine (1.14) to pyruvate (1.11), water and ammonia. d) Tyrosine phenol-
lyase (TPL) breaks down L-tyrosine (1.15) to α-ketobutyrate, phenol and ammonia. e) 
Cystathionine γ-lyase (CGL) breaks down L-cystathionine (1.16) to α-ketobutyrate 
(1.3), L-cysteine (1.17) and ammonia. f) Cystathionine γ-synthase (CGS) condenses 
succinyl-O-L-homoserine (1.18) and L-cysteine (1.17) to L-cystathionine (1.16) and 
succinate (1.19). The figure was adapted from Eliot and Kirsch (2004). 
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L-Methionine γ-lyase belongs to the aspartate aminotransferase family, also known as fold-
type I family. The enzyme is catalytically active as homodimers or higher oligomers with 
two catalytic active sites per homodimer (Schneider et al., 2000). Each monomer has a 
central domain that is composed of seven-stranded β-sheets, and a C-terminal domain that is 
composed of three- or four-stranded β-sheets (Schneider et al., 2000) (Figure 1.7a). PLP is 
covalently attached to the ε-amino group of lysine on the central domain, and is situated 
between the cleft of the central and C-terminal domains (Figure 1.7b). The phosphate moiety 
of PLP contacts the central domain of the adjacent monomer (Figure 1.7c). The catalytic 
residues are situated between the cleft of the two domains and at the dimer interface. The 
domains move significantly upon substrate binding, which is believed to contribute to the 
substrate specificity and reaction type (Eliot and Kirsch, 2004; Ishijima et al., 2000). Thus, a 
catalytically active enzyme for fold-type I family requires burial of the PLP cofactor between 
the two domains and dimerization of the two subunits. 
Another feature among the fold-type I family is the metal requirement in order to induce 
conformations that influence the catalytic activity as reported for 2,2-dialkyl- glycine 
decarboxylase, tyrptophanase and tyrosine phenol-lyase (TPL) (Woehl and Dunn, 1995). 
Similarly, activation by monovalent metal ions in other as of yet unreported families is 
expected, considering the high structural similarities with known monovalent-dependent 






Figure 1.7. The domains and secondary structure of a fold-type I family enzyme. 
a) The secondary structure of TvMGL1 displaying β-strands (blue) and α-helices 
(grey; transparent). b) The space fill structure displaying the N-terminal (blue), central 
(orange, transparent) and C-terminal (green) domains of TvMGL1, and PLP cofactor 
(light blue and red). c) The space fill structure of the PLP cofactor (light blue and red) 
is situated in the middle of the central and C-terminal domain (silver), which is kept in 
place by an internal aldimine linkage and dimerization of the adjacent subunit 
(transparent, pink). The images (PDB 1E5F) were rendered in Visual Molecular 





 respective γ and β-eliminating enzymes, have a very low sequence identity but they are 
structurally similar (an RMSD of 3.2 Ǻ; I. Moya, unpublished observations). The potential 
ligands to coordinate a monovalent cation in MGL may involve the side chains of Q31 (from 
an adjacent subunit) and D249, and the carbonyl backbone of D216. These predictions are 
based on the structural alignment with TPL, where potassium is coordinated to the carbonyl 
backbone of G52 (from an adjacent subunit) and E69, and the carbonyl side chain of Q262 




Figure 1.8. Structural alignment of TPL and TvMGL1 displaying a potential 
metal coordination site. 
TPL (thin lines; PDB 2V1H) displaying chelating residues (G52, E69 and Q262; 
labeled green) coordinated to potassium (wire mesh), and its catalytic residue K257. 
TvMGL1 (thick lines; PDB 1E5F) displaying potential chelating residues (N31, D216 
and D249; labeled purple) coordinated to water 207 (red sphere); and its catalytic 
residue (K209). The images were rendered in Visual Molecular Dynamics v1.9 














Based on structural and kinetic studies of tyrosine phenol-lyase (TPL) and tryptophan 
indole-lyase, monovalent cations are known to increase the affinity of the apoenzyme for the 
cofactor, strengthen intersubunit interactions, and help in labilization of the Cα proton for the 
external aldimine complex (Honda and Tokushige, 1986; Kumagai et al., 1970; Toraya et al., 
1976). For example, a pentagonal bipyramidal coordinated potassium ion (in C. freundii 
TPL) forms a hydrogen bonding network with S51, and as a result this residue is proposed to 
maintain the basicity of the catalytic residue K257 and proper orientation of the PLP cofactor 
(Figure 1.9) (Demidkina et al., 2009). The latter idea is consistent with the predictions of 
Ivanov and Karpeisky (1966) for aspartate aminotransferase, in which the positioning of the 
coenzyme establishes an optimal active-center conformation for catalysis. In other words, a 
change in the position of the cofactor will alter the protonation state of the aldimine (internal 
or external), and in turn influence the intermediate structures of the enzyme associated with 
substrate binding and catalysis (Hayashi et al., 1998). Thus, the coordination of a monovalent 
cation serves as an allosteric effector for β-lyase enzymes in the catalysis of the substrate 
(Woehl and Dunn, 1995), but there are no reports of such a requirement in γ-eliminating 





Figure 1.9. Hydrogen bonding network established between the bound potassium 
and the active site residues of CfTPL. 
The hydrogen bonding network (dashed purple lines) is believed to play an important 
role in catalysis for CfTPL, which is established among potassium (green sphere), 
water molecules (red sphere), S51, K256, K257, Y71 and PLP-methionine aldimine 
linkage (ball and stick; P in yellow; O in red; C in turquoise; N in blue; S in grey) as 
previously reported by Demidkina et al. (2009). The image was rendered in Visual 
Molecular Dynamics v1.9 by aligning CfTPL structures PDB 2V1H and PDB 2EZ1 
(Humphrey et al., 1996). 
 
1.6. Reactions Catalyzed by L-Methionine γ-lyase  
In the literature, homologous L-methionine γ-lyases are known to carry out two or more of 
the following reactions: α,γ-elimination, α,γ-replacement, α,β-elimination and α,β-
replacement of the respective S-homocysteine and S-cysteine derivatives (Dias and Weimer, 










1977; Tokoro et al., 2003). For example, P. putida (Pp)MGL is the only enzyme studied to 
date that catalyzes both γ-replacement of O-substituted homoserine derivatives to produce S-
substituted homocysteine derivates, and β-replacement of O-substituted serine derivatives to 
produce S-substituted cysteine derivatives (Inoue et al., 2000; Takada et al., 1988). However, 
there are no reports of the enzyme displaying CGS activity, i.e., the γ-replacement reaction 
involved in the biosynthesis of L-cystathionine from L-cysteine and O-succinyl-homoserine 
(Sato and Nozaki, 2009). 
The catalytic mechanism of the enzyme is proposed to follow a series of deprotonation and 
reprotonation steps at the Cα and Cβ atoms as reported for the orthologous cystathionine γ-
lyase enzyme, and homologous PpMGL enzyme (Figure 1.10) (Esaki et al., 1985; 
Messerschmidt et al., 2003). Briefly, the enzyme forms an internal aldimine linkage (1.21) 
between PLP and the catalytic active site residue, lysine (Figure 1.10 a). The binding of L-
amino acid facilitates transaldimination with lysine to form an external aldimine linkage 
(1.22) between PLP and the amino acid, thereby freeing the lysine side chain for general 
acid-base catalysis. Thus, the free lysine side chain is able to labilize the α- and β-hydrogen 
atoms of the amino acid, which leads to a shift of electrons in the conjugated π-system 
(Figure 1.10 b and c). The catalytic tyrosine is believed to aid in the elimination of the thiol 
group as reported for PpMGL, and the hydrolysis of the ketimine (1.24) is believed to occur 





Figure 1.10. Overview of the proposed key reaction steps in the γ-elimination of 
methionine by TvMGL1. 
a) The aldehyde group of PLP forms an internal aldimine (1.21) linkage with K209. 
The linkage is replaced by the incoming L-methionine substrate (1.2) to form b) an 
external aldimine (1.22). Deprotonation of the α-carbon atom and subsequent c) β-
carbon atom of the amino acid lead to the γ-elimination of the methanethiol moiety. d) 
Deprotonation of the C4’ proton and shift of electrons are believed to form e) an 
iminoacrylate (1.23). The compound undergoes transaldimination with lysine to 
release f) α-iminobutanoate (1.24). The non-enzymatic hydrolysis of the ketimine 
(1.24) produces g) the final end products, α-ketobutyrate (1.3) and ammonia. The 
reaction mechanism was adapted from Esaki et al. (1985) and Messerschmidt et al. 











Based on 1H-NMR for the catalysis of L-methionine by PpMGL, the rate of α-proton 
abstraction is 2-fold greater than the β-deprotonation step, and 40-fold greater than the γ-
elimination step (Esaki et al., 1985), which is similar to reports for the orthologous CGL and 
CGS enzymes (Guggenheim and Flavin, 1969; Posner and Flavin, 1972; Washtien et al., 
1977). The rate determining step is believed to occur after the elimination of the thiol group, 
which is consistent with the reports for CGS from Salmonella typhimurium (Johnston et al., 
1979). Both CGL and CGS enzymes are reported to be stereospecific for one of the β-
hydrogens on L-homocysteine; however, the stereochemistry was not identified (Posner and 
Flavin, 1972; Washtien et al., 1977). On the other hand, MGL did not exhibit any 
stereospecificity for the β-hydrogen atoms of L-methionine nor S-methyl-L-cysteine (Esaki et 
al., 1985), and there is currently no explanation for this lack of stereospecificity. 
 
1.7. Methionine-dependent Tumors 
A characteristic of many cancer cell lines is their absolute requirement for plasma L-
methionine, while normal cells are able to tolerate a restriction of exogenous L-methionine 
(Cellarier et al., 2003). Methionine-dependent tumor cells have an abnormally high rate of 
methionine utilization for methylation reactions, and therefore, require more methionine than 
the cells can synthesize from homocysteine during methionine starvation (Coalson et al., 
1982; Stern and Hoffman, 1984; Tisdale, 1980). Thus, when these tumor cells are deprived 
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of methionine in homocysteine-containing medium in vitro, they reversibly arrest in the late 
S/G2 phase of the cell cycle (Guo et al., 1993; Hoffman and Jacobsen, 1980). 
A therapeutic approach to deplete methionine from tumors is to treat the cells with 
recombinant MGL from Pseudomonas putida (PpMGL). The growth of human tumors in 
vivo and in vitro (xenographed in nude mice) is reported to be inhibited upon treatment with 
recombinant PpMGL when compared to normal cells (Tan et al., 1997). Therapeutic efficacy 
is found to improve when recombinant PpMGL is combined with anticancer drugs such as 
cisplatin, 5-fluorouracil, nitrosourea, and vincristine (Hu and Cheung, 2009; Kokkinakis et 
al., 2001; Tan et al., 1999; Yoshioka et al., 1998). Reduction in cell growth is also achieved 
by integrating P. putida mgl gene into human lung cancer cells by using a retroviral vector 
and treatment with exogenous recombinant ppMGL, in order to deplete intracellular and 
extracellular methionine levels (Miki et al., 2000; Miki et al., 2001). Treatment of the 
transduced cells with exogenous selenomethionine is found to inhibit tumor cell growth, 
since the processing of selenomethionine by MGL is implicated in the release of 
methylselenol, a catalyst for generating reactive oxygen species and in turn oxidize 
intracellular thiols (Chaudiere et al., 1992; Clark et al., 1996; Miki et al., 2001; Yan and 
Spallholz, 1993). Coupling the recombinant PpMGL to methoxypolyethylene glycol 
succinimidyl glutarate was found to improve the pharmacokinetics and reduce 
immunogenicity in primates relative to the unmodified enzyme (Yang et al., 2004). Thus, 
there is evidence to suggest that methionine depletion by PpMGL and in combination with a 




1.8. Cysteine Biosynthesis Pathway 
1.8.1. An Overview of Sulfur Biochemistry in Living Organisms 
In living organisms, L-methionine and L-cysteine play essential roles in protein synthesis, 
methylation reactions, polyamine biosynthesis (e.g., proper cell development), anti-oxidative 
stress defense (glutathione/trypanothione), and iron-sulfur cluster biosynthesis (e.g., energy 
metabolism) (Ali and Nozaki, 2007; Ravanel et al., 1998; Sekowska et al., 2000; Stipanuk, 
1986; Thomas and Surdin-Kerjan, 1997). The strategy that organisms utilize in order to 
biosynthesize sulfur-containing amino acids varies from organism to organism (Figure 1.11). 
In humans, L-methionine must be incorporated into the diet in order to biosynthesize L-
cysteine; this occurs through the forward transsulfuration pathway (Stipanuk, 1986). In yeast, 
either cysteine or methionine can be supplemented to its diet in order to biosynthesize 
methionine or cysteine, respectively (Thomas and Surdin-Kerjan, 1997). Alternatively, the 
organism may synthesize the sulfur-containing amino acids by utilizing inorganic sulfate via 
de novo cysteine biosynthesis pathway (Thomas and Surdin-Kerjan, 1997). Thus, yeast have 
a forward transsulfuration pathway (Figure 1.12a), a reverse transsulfuration pathway (Figure 
1.12b) and a sulfide biosynthetic pathway (sulfate to sulfide). Escherichia coli and plants 
utilize the forward transsulfuration pathway such that methionine is biosynthesized from 
cysteine, or may utilize inorganic sulfate via de novo cysteine biosynthesis (Ravanel et al., 
1998; Sekowska et al., 2000). On the other hand, E. histolytica and T. vaginalis do not have a 
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forward or a reverse transsulfuration pathway, but have a methionine catabolic pathway (and 
elements of a de novo sulfide biosynthetic pathway for cysteine biosynthesis in E. 
histolytica) (Carlton et al., 2007; Loftus et al., 2005). These differences in cysteine 
metabolism between humans and parasites are of particular interest, especially for the future 
development of anti-parasitic compounds. 
 
 
Figure 1.11. An overview of the biosynthetic pathways for thiol-containing amino 
acids in humans, yeast, E. coli, plants, E. histolytica and T. vaginalis. 
The forward transsulfuration pathway is present in humans and yeast. The reverse 
transsulfuration pathway is present in yeast, plants and E. coli. The sulfide and de 
novo cysteine/homocysteine biosynthesis is present in yeast, plants and E. coli. The 
methionine catabolic pathway is present in E. histolytica and T. vaginalis. The figure 
was adapted from Moya et al. (Moya et al., 2009) and based on several studies 
(Carlton et al., 2007; Loftus et al., 2005; Ravanel et al., 1998; Sekowska et al., 2000; 








Figure 1.12. Forward and reverse transsulfuration pathways. 
a) Forward transsulfuration pathway in humans: cystathionine β-synthase (CBS) 
condenses L-homocysteine (1.1) and L-serine (1.14) to L-cystathionine (1.16), and 
cystathionine γ-lyase (CGL) breaks down L-cystathionine (1.16) to α-ketobutyrate 
(1.3), ammonium and L-cysteine (1.17). b) Reverse transsulfuration pathway in E. 
coli: cystathionine γ-synthase (CGS) condenses L-cysteine (1.17) and O-succinyl-L-
homoserine (1.18) to succinate and L-cystathionine (1.16), and cystathionine β-lyase 
(CBL) breaks down L-cystathionine (1.16) to L-homocysteine (1.1), α-ketobutyrate 
(1.3) and ammonium. 
1.1 1.14 1.16 1.3 1.17 




1.8.2. Methionine Catabolism 
In E. histolytica and T. vaginalis, L-cysteine is an essential nutrient for growth and for 
tolerance to reactive oxygen species (Bruchhaus et al., 1998; Coombs et al., 2004; Trussell, 
1946; Vicente et al., 2008). The anaerobic parasites are known to catabolize methionine to 
homocysteine, but lack enzymes to convert homocysteine to cysteine and vice versa (Figure 
1.13 a and b); thus, the parasites lack a forward and a reverse transsulfuration pathway, 
respectively (Figure 1.12 a and b) (Carlton et al., 2007; Loftus et al., 2005). In the forward 
transsulfuration pathway in humans for example, the enzyme cystathionine β-synthase 
condenses homocysteine (1.1) and serine (1.14) to produce cystathionine, which is utilized 
by cystathionine γ-lyase to produce cysteine (1.17) and α-ketobutyrate (1.3; Figure 1.12a) 
(Stipanuk, 1986). 
The absence of a forward transsulfuration pathway in the two parasitic protozoans is 
expected to result in an accumulation of homocysteine, and consequently interfere with 
cellular methylation reactions due to an imbalance in their methionine:homocysteine ratios. 
Analysis of the parasite’s genome suggests that homocysteine cannot be converted to 
methionine because the organism lacks methionine synthase genes (Anderson and Loftus, 
2005; Carlton et al., 2007; Loftus et al., 2005; Westrop et al., 2006). A possible solution in 
preventing the accumulation of homocysteine in a parasite may be resolved by MGL (4; a 





Figure 1.13. Methionine catabolism and de novo cysteine biosynthesis in E. 
histolytica and T. vaginalis. 
The solid black arrow indicates that the enzyme is present in E. histolytica and T. 
vaginalis, while the dashed black arrow indicates that the enzyme is absent in both 
parasites. The solid blue arrow indicates that the enzyme is present in T. vaginalis. 
The solid red arrow indicates that the enzyme is present in E. histolytica, while the red 
dashed arrow is a proposed route in E. histolytica. The protozoan parasites lack both 
a) a forward transsulfuration pathway and b) a reverse transsulfuration pathway. 1) 
methionine adenosyltransferase, 2) S-adenosyl-L-methionine dependent 
methyltransferase, 3) S-adenosyl-L-homocysteine hydrolase, 4) L-methionine γ-lyase, 
5) phosphoglycerate dehydrogenase, 6) phosphoserine aminotransferase, 7) 
phosphoserine phosphatase, 8) serine O-acetyltransferase, 9) type A cysteine 
synthase, 10) Type B cysteine synthase, 11) zinc-dependent metalo- 
protease/thioredoxin reductase, 12) ATP sulfurylase, 13) APS kinase, 14) methionine 
synthase. The figure was adapted from Moya et. al. (2009). 
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able to catabolize both L-methionine and L-homocysteine (Figure 1.13) (Lockwood and 
Coombs, 1991; Tokoro et al., 2003). The turnover of L-homocysteine by MGL produces 
H2S, which is proposed to be incorporated into the de novo biosynthesis of cysteine (Sato et 
al., 2008). The α-keto by-products generated from MGL may serve as an energy source for 
the organism (Brown et al., 1999; Samarawickrema et al., 1997). Thus, imbalances in 
methionine/homocysteine ratios may be restored by the activity of MGL, and the by-products 
generated may be incorporated into de novo cysteine biosynthesis and energy metabolism. 
 
1.8.3. Sulfide Biosynthetic Pathway and de novo Cysteine Biosynthesis 
Based on genomic analysis of T. vaginalis and E. histolytica, the two genomes have been 
found to contain remnants of the de novo cysteine biosynthetic pathway (Carlton et al., 2007; 
Loftus et al., 2005), and remnants of the sulfide biosynthetic pathway (12 and 13) in E. 
histolytica (Figure 1.13). For the de novo cysteine biosynthetic pathway in E. histolytica, the 
parasite produces O-acetylserine from serine by serine O-acetyltransferase (SAT, 8), and is 
subsequently converted to cysteine by cysteine synthase (CS, 10; Figure 1.13) (Nozaki et al., 
1998; Nozaki et al., 1999). Entamoeba histolytica lacks genes for O-phosphoserine 
phosphatase (7), which is involved in the dephosphorylation of O-phosphoserine to serine; 
but are present in T. vaginalis (Figure 1.13) (Carlton et al., 2007; Westrop et al., 2006). On 
the other hand, T. vaginalis lacks SATs and enzymes involved in de novo sulfide 
biosynthesis (Loftus et al., 2005; Westrop et al., 2006). Thus, in E. histolytica, cysteine 
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synthase is likely to biosynthesize L-cysteine from O-L-acetylserine. However, in T. 
vaginalis, the preferred substrate for CS in order to biosynthesis L-cysteine is uncertain. 
Analysis of the genes encoding for CS in the two parasites indicate different CS 
isoenzymes. E. histolytica encodes for three type A CS enzymes (9), while T. vaginalis 
encodes for six type B CS enzymes (10; Figure 1.13) (Westrop et al., 2006). Even though the 
two types of isoenzymes carry out β-replacement reactions and accept O-L-acetylserine and 
sulfide as substrates, type B CS isoenzymes are known to accept thiosulfate or other larger 
thiol donors (Nozaki et al., 2000; Westrop et al., 2006). 
In T. vaginalis, the genome lacks SAT genes and there are no reports of cysteine 
biosynthesis from O-L-acetylserine. There are genes in the parasite that encode for 3-
phosphoglycerate dehydrogenase and an O-phosphoserine aminotransferase in order to 
biosynthesize O-L-phosphoserine precursor (Carlton et al., 2007; Westrop et al., 2006). Type 
B CS from T. vaginalis (10) is reported to utilize O-L-phosphoserine (a KM of 230 mM) as 
substitute for O-L-acetylserine (a KM of 40 mM) in the biosynthesis of cysteine (Figure 1.13) 
(Westrop et al., 2006), which has been reported for CS from Aeropyrum pernix (Mino and 
Ishikawa, 2003). In Mycobacterium tuberculosis, O-phosphoserine is utilized as a substrate 
for type B CS enzyme, via a novel cysteine biosynthetic pathway (Agren et al., 2008; Burns 
et al., 2005). The enzyme is characterized as an O-phosphoserine sulfhydrylase that accepts 
O-L-phosphoserine as a substrate, and its sulfur donor is a small protein (CysO) that is 
thiocarboxylated at the C-terminus (CysO-SH, 10; Figure 1.13) (Agren et al., 2008). The 
enzyme produces a CysO-cysteine adduct, and in turn is cleaved by a zinc-dependent 
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metalloprotease (11) to produce cysteine and CysO (Figure 1.13) (Agren et al., 2008). Thus, 
type B CS enzymes in T. vaginalis may have an O-phosphoserine sulfhydrylase activity, and 
belong to a similar pathway as described for M. tuberculosis. The absence of type A CS and 
SAT enzymes in T. vaginalis should not be ruled out because the sequence of its (entire) 
genome is incomplete. 
 
1.9. Purpose of Study 
The overuse and misuse of metronidazole family of drugs for treating human protozoan 
infections have led to an increased incidence of drug resistant strains. The enzyme, MGL is 
proposed to be an alternative, potential drug target in order to treat human protozoan 
infections. The purpose of the thesis is to understand the chemistry of the enzyme, TvMGL 
in respect to its reaction mechanism by utilizing fluorinated L-methionine analogs as probes 
and by site-directed mutagenesis. The chemistry of the products generated from the 
processing of the fluorinated methionine analogs by TvMGL1 was examined by 19F-NMR 
spectroscopy, high level thermochemistry calculations, PLP model studies, cross-linking 
studies and cellular toxicity assays. The knowledge gained from this study will be applied to 
a second generation of fluorinated methionine analogs that takes into consideration the 
mechanism of the enzyme and chemistry of the fluorinated substitution within the compound. 
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CHAPTER 2  
ROLE OF THE ACTIVE SITE RESIDUE C113 IN TRICHOMONAS 
VAGINALIS L-METHIONINE γ-LYASE 1 
 
2.1. Authors’ Contribution 
Dr. G. Coombs provided the mgl1 gene from Trichomonas vaginalis G3. I. Moya cloned the 
mgl1 gene and mutants into the pET28b vector. Dr. Richard Smith performed the ESI-MS 
experiments for the enzymes. Jessica Dubrick generated the TvMGL1 mutants, C113S and 
C113A. All other work was performed by I. Moya. Dr. J. Honek conceived the project and 
discussed the data with I. Moya. 
 
2.2. Introduction 
The active site residue C113 in TvMGL1 is proposed to aid in the catalytic efficiency of the 
enzyme such as substrate specificity and a general acid as indicated by site-directed 
mutagenesis studies and X-ray crystallography structures (Figure 2.1) (Sato and Nozaki, 
2009). The active site cysteine is conserved in homologous MGLs from bacteria to protozoa, 
but dispensable in orthologous γ-eliminating enzymes such as cystathionine γ-lyase and 
cystathionine γ-synthase (McKie et al., 1998; Nakayama et al., 1988a). In this chapter, we 
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present numerous reports that address the role of the catalytic cysteine, and our own work on 
the mutation of this residue. 
 
 
Figure 2.1.  The active site of TvMGL1 homodimer. 
The active site of TvMGL1 displaying the catalytic residues: K209 bound to the PLP 
cofactor, Y111 and C113 (PDB 1E5E; unpublished crystal structure). The image was 
rendered in Visual Molecular Dynamics v1.9 (Humphrey et al., 1996). 
 
2.3. Studies on the Functional Role of the Cysteine Residue 
In TvMGL1, site-directed mutagenesis studies on C113 suggest that the side chain plays 
an important role in the catalysis of L-homocysteine (2.1) and L-methionine (2.2) (McKie et 
al., 1998). Mutating the residue C113 to Gly, which is conserved among orthologous α,γ-
eliminating enzymes, leads to a reduction in both α,β elimination and α,γ eliminating 
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reactions, a 3-fold reduction in the turnover rate of L-cysteine and a 13-fold reduction in the 
turnover rate of L-methionine, respectively (McKie et al., 1998). The mutations do not enable 
the enzyme to utilize cystathionine nor facilitate α,γ-replacement reactions, considering that 
the requirement is likely to be dictated by the polarity of the binding pocket and not by a 
single amino acid side chain in the active site (Motoshima et al., 2000). In a similar study, 
the equivalent cysteine residue in PpMGL is implicated in catalysis, as suggested by 
inactivation of the enzyme as a result of the covalent modification of cysteine residues by N-
(bromoacetyl) pyridoxamine phosphate (2.3; Figure 2.2b) (Nakayama et al., 1988b). Further 
studies with a thiol specific cyanylating reagent, 2-nitro-5-thiocyanobenzoic acid (2.4; Figure 
2.2c), suggest that the active-site cysteine residue is essential for α,γ-elimination but not  α,β-
elimination reactions (Nakayama et al., 1988a). The α,γ-elimination activity of 
thiocyanylated enzymes (2.5) can be restored with L-homocysteine derivatives; it is believed 
that the mercaptan leaving group exchanges with the cyanyl group of the modified cysteine 
within the active site. These findings are also consistent with the modification of the cysteine 
residue of PpMGL by the mechanistic-based inhibitor, 2-amino-4-chloro-5-(p-nitrophenyl-
sulfinyl)pentanoic acid (Johnston et al., 1980). Thus, the active site cysteine residue in MGL 




Figure 2.2.  Reaction overview of the catalysis of L-homocysteine derivatives by 
TvMGL1, and modification of active site thiols in enzymes. 
a) Reaction overview of the catalysis of L-homocysteine (2.1) and L-methionine (2.2) 
by TvMGL1. b) Inactivation of the active site cysteine of an enzyme by N-
(bromoactyl)-pyridoxamine 5`-phosphate (2.3). The figure was adapted from Higgins 
and Miles (1978). c) Cyanylation of the active site cysteine to thiocyanate (2.5) by 2-
nitro-5-thiocyanobenzoic acid (2.4). The figure was adapted from Patchornik et al. 
(1970). 
 
With the removal or inactivation of the catalytic cysteine residue of MGL, the enzyme’s 
α,β-elimination activity remains (McKie et al., 1998; Sato and Nozaki, 2009). The pH-
dependencies of the main kinetic parameters of Citrobacter freundii (Cf)MGL suggest that 
the elimination reactions are aided by two general acids that have a pKa of 8.7 (Faleev et al., 
2009). The authors propose that Y58 in CfMGL acts as the general acid in the catalysis of 
α,β-reactions of substrates such as S-methyl-L-cysteine (Y56 equivalent in TvMGL1), while 















methionine (Y111 equivalent in TvMGL1) because of its proximity to the thiol leaving group 
(Figure 2.1). However, the authors ruled out the possibility that the catalytic C115, adjacent 
to Y113, acts as a general acid because it is not within hydrogen bonding distance to the 
methanethiol leaving group of methionine, as indicated by their structural model (Faleev et 
al., 2009). 
The catalytic cysteine is implicated in substrate specificity as reported for EhMGL, 
TvMGL and PpMGL (Kudou et al., 2008; Kudou et al., 2007; McKie et al., 1998; Sato et al., 
2008). The crystal structure of PpMGL suggests that the catalytic residue C116 forms an 
extensive H-bonding network within the active site, such as the hydrogen bonding network 
established between Y114 and residues on the adjacent subunit (K240, D241 and R61) 
(Kudou et al., 2007). The notion is supported by site-directed mutagenesis on the catalytic 
C116 residue in PpMGL (Kudou et al., 2008). For one of the substitutions, the C116H 
mutant increases the turnover rate of β-elimination by ~20-fold for the cysteine substrate, 
while the γ-elimination turnover rate decreases by ~300-fold for the methionine substrate 
when compared to wild-type enzyme (Kudou et al., 2008). Thus, catalytic residue C116 in 
PpMGL is not only important in the α,γ-elimination reaction, but may influence substrate 
specificity due to its hydrogen bonding network within the active site. 
The goal of this study was to examine the catalytic role of C113 in TvMGL1 by site-
directed mutagenesis (C113S mutant) and its relation to previous studies (Kudou et al., 2008; 
McKie et al., 1998; Sato et al., 2008). The particular mutation was to allow for a similar 
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structure of the side chain but alter the thiol group, which was replaced by a hydroxyl group. 
To our knowledge, this type of mutation has never been studied for the TvMGL enzyme. 
 
2.4. Results and Discussion 
The mgl1 gene from pGL14, which was a gift from Dr. G. Coombs (University Strathclyde, 
Glasgow, UK), was cloned into the pET28b vector possessing an inducible promoter for 
overexpression, and a thrombin-cleavable site upstream of the hexahistidine tag, which was 
incorporated at the C-terminus of the enzyme (termed TvMGL1p28). The enzyme was 
overexpressed in E. coli and purified by a Ni2+-chelating resin. The latter construct was used 
as a template to generate TvMGL1 C113S, termed TvMGL1p28 C113S (presented here); and 
TvMGL1 C113A, termed TvMGL1p28 C113A (not examined in this study). 
The Michaelis-Menten Kinetics of the enzyme were determined by a 3-methyl-2-
benzothiazolone hydrazone hydrochloride (MBTH; 2.6) assay method as previously reported 
(Figure 2.3) (Soda, 1968). Compared to TvMGL1 from the pGL14 construct, TvMGL1p28 
had a 1.2-fold lower turnover rate of L-methionine and the Km value for the substrate was 
within experimental error (Table 2.1). The cause of the slightly lower activity is currently 
unclear (trace amounts of impurities, linker region, or a truncated N-terminus), but in general 





Figure 2.3. An MBTH (2.6) assay method for detection of α-ketobutyrate (2.7) 
generated from the turnover of L-methionine by TvMGL1. 
 








The standard errors were obtained from three independent experiments. *As reported by Moya et al. 
(2011), and **estimated value from Mckie et al. (1998). ND, not determined. 
 
Comparing the TvMGL1p28 C113S mutant withTvMGL1p28, the turnover rate of L-
methionine was reduced by approximately 7-fold, with no significant difference in its Km 
value for the substrate (Table 2.1). In a previous study, TvMGL1 C113G mutant is reported 
to have an approximately 6-fold reduction in the turnover rate of L-homocysteine, and no 
significant changes in its Km value when compared to the wild-type enzyme (McKie et al., 
1998). However, the study did not examine the Michaelis-Menten values for the mutant in 
the presence of L-methionine. EhMGL1 C110S mutant is reported to have a 2-fold reduction 
Enzyme Construct Km**** kcat****
 mM**** min-1***
TvMGL1 (pGL14) 0.22 ± 0.05* 416 ± 15**
 0.19 ± 0.01* 403 ± 12**
 ND* 453 ± 14**
TvMGL1p28 0.17 ± 0.03* 347 ± 17**




in its turnover rate of L-methionine and no significant changes in its Km value when 
compared to the wild-type enzyme (45% sequence identity) (Sato et al., 2008). The 
equivalent mutation in PpMGL, C116S is reported to have a 14-fold reduction in turnover 
rate of L-methionine and an 8-fold reduction in Km value for the substrate when compared to 
the wild-type enzyme (42% sequence identity) (Kudou et al., 2008). Overall, TvMGL1 C113 
side chain plays an important role in catalysis and is consistent with homologous enzymes 
studied to date, while dispensable among reported orthologous enzymes such as 
cystathionine γ-lyase and cystathionine γ-synthase (Sato and Nozaki, 2009). 
 
2.5. Conclusion and Future Work 
The activity of TvMGL1p28 is slightly lower than TvMGL1 from the pGL14 construct. 
Despite these concerns, the single mutation for the pET28 constructs (all things being equal) 
allowed for direct comparison of the effect of the C113S mutation. The mutant, TvMGL1p28 
C113S had a reduced turnover rate relative to the wild type enzyme, which might suggest 
that the side chain plays an important role in the activity of the enzyme. This notion is 
consistent with proposals reported for homologous MGLs (Kudou et al., 2008; McKie et al., 
1998; Nakayama et al., 1988a; Sato et al., 2008), and C113 proximity to Y111 in the crystal 
structure of TvMGL1 (a distance of 3.7 Å; PDB 1E5F, unpublished structure). However, a 
definitive understanding into the exact role of C113 side chain, such as its role in substrate 
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specificity, will require structural and biophysical data in order to substantiate the kinetic 
values, which has not been reported for MGL enzymes studied to date. 
 
2.6. Materials and Methods 
2.6.1. General Experimental 
The mgl1 gene from T. vaginalis was a gift from Dr. G. Coombs (University of Strathclyde). 
Derivatizing agent, MBTH and pyridoxal 5’-phosphate-HCl were purchased from Sigma 
Aldrich (Milwaukee, WI). Buffers, isopropyl β-D-1-thiogalactopyranoside (IPTG), and 
dithiothreitol (DTT) were purchased from Bioshop Canada Inc. (Burlington, ON). 
Kanamycin (KAN) and ampicillin (AMP) were purchased from EMD Chemicals Inc. 
(Gibbstown, NJ). 
Bradford assay for measuring protein concentration was prepared according to procedures 
reported by Bradford (1976). 
 
2.6.2. TvMGL1 C113 Mutants 
The mgl1 gene, previously cloned into the pET28b vector (Novagen, Madison, WI) (Moya et 
al., 2011), was used as a template to generate the C113A and C113S mutants. The C113A 
mutant was generated by overlap extension PCR with Pwo SuperYield DNA polymerase 
(Roche Applied Science, Indianapolis, IN) as described by Sambrook and Russell (2001). 
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The primer pair (Invitrogen, Burlington, ON) termed “MGL1 forNcoI” (5’-
GATATACCATGGCGCACGAGAGAATGAC-3’) and “MGL1 C113A Rev” (5’-
GCATGTGTggcGCCATAAAGGCACTC-3’) generated the N-terminal fragment, which 
contained the NcoI restriction site (underlined) and alanine codon (lower case letters), 
respectively. The primer pair termed “MGL1 C113A For” (5’-CTTTATGGCgccACACA-
TGCTCTCTTTG-3’) and “MGL1 rev1bXhoI” (5’-GTAAATCTCGAGGCTACCACGT-
GGCACCAGAC-3’) generated the C-terminal fragment, which introduced the alanine codon 
(lowercase letters) and the XhoI site (uppercase lettering and underlined), respectively. The 
N-terminal fragment and C-terminal fragment were combined and amplified with the primer 
pair termed “MGL1 forNcoI” and “MGL1 rev1bXhoI”, in order to generate the ORF of 
mgl1. Amplification of the PCR products was carried out under the following conditions: 
denatured at 95°C, 1’; 18 cycles (95°C, 1’; 63°C, 1’; 72°C, 1’45”); and 11 cycles (95°C, 1’; 
63°C, 1’; 72°C, 1’ 35”) and 72°C, 5’. The PCR products were recovered using a Silica Bead 
DNA Gel Extraction Kit (Fermentas Inc., Hanover, MD). The PCR products and the pET28b 
vector were doubled digested with NcoI and XhoI restriction enzymes (NEB, Ipswich, MA), 
purified using the Silica Bead DNA Gel Extraction kit, and ligated with T4 DNA ligase 
(NEB). The ligation mixture was transformed into electrocompetent XL-1 Blue cells 
(Stratagene, La Jolla, CA) and selected on LB-agar media with 35 mg/L kanamycin (KAN). 
The plasmids with the insert were purified from the transformed cells using a QIAGEN 
miniprep kit (QIAGEN, Valencia, CA), and then transformed into electrocompetent BL21 
(DE3) cells. The procedure to generate the C113S mutant was similar as the methods 
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described above for the C113A mutant, except that primer termed “TvMGL1 C113S For” 
(5’-CCTTTATGGCtccACACA-TGCTCTCTTTG-3’) was used for generating the N-
terminal fragment, and the primer termed “TvMGL1 C113S Rev” (5’-AGCATGTGTgga-
GCCATAAAGGCACTC-3’) was used for generating the C-terminal fragment. All of the 
gene sequences for the MGL1 constructs were verified by DNA sequencing (DNA 
Sequencing Facility, Department of Biology, University Waterloo, Waterloo, ON). 
 
2.6.3. Agarose Gel Electrophoresis 
The DNA samples were mixed in a final concentration of 1X loading buffer [0.04% (w/v) 
bromophenol blue, 5% (v/v) glycerol], and ~4 µL of the mixture was loaded into the agarose 
gel. The samples were resolved at 120 volts for 12 min in 1X TAE buffer (40 mM Tris-
acetate, 1 mM EDTA, pH 8.0), and visualized with a UV lamp at 365 nm. The agarose gels 
consisted of 1.0% to 1.4% (w/v) agarose, 1X TAE buffer, and 0.5 µg/ml ethidium bromide. 
 
2.6.4. Cell Culture and Expression of Enzyme 
The pET28b construct containing the gene of interest (mgl1 or mgl1 C113A, mgl1 C113S) 
was transformed into E. coli BL21 (DE3) (Stratagene) by electroporation (5 msec at 1,600 
volts), and recovered in 1 mL LB media for one hour at 37°C. The transformants were 
inoculated into 10 mL LB media supplemented with 35 μg/mL KAN, and grown overnight in 
a shaking incubator at 37°C. The overnight culture was inoculated in 1 L LB media 
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supplemented with 35 μg/mL KAN, grown to an OD600 of 0.6 at 37°C, and subsequently 
induced with 0.12 mM IPTG for 3 hr in a shaking incubator at 37°C. The cultures were 
harvested by centrifugation at 4,600 xg for 20 min at 10°C, and the cell pellets were stored at 
-20°C for future use. The growth conditions for MGL1p28 was modified as follows: the 
overnight culture was inoculated in 1 L Terrific Broth media supplemented with 50 μg/mL 
KAN and 0.8% glucose, grown to an OD600 of 0.6 at 37°C, and subsequently induced with 
0.12 mM IPTG for 3 hr in a shaking incubator at 21°C. 
 
2.6.5. Cell Lysis and Protein Purification 
The cell pellets containing the His-tagged recombinant enzyme (TvMGL1p28 or mutant) 
were thawed at 22°C and suspended in ice-cold binding buffer A [30 mM 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), pH 7.5, 500 mM NaCl]. The cell 
suspension was homogenized four-times on ice by sonication (3” pulse, 6” rest; 90” total) 
and then centrifuged at 21,000 xg for 30 min at 10ºC. The DNA and cell debris was removed 
from the supernatant with the DE52 anion exchange column (Sigma Chemicals CO, St. 
Louis, MO), which was pre-equilibrated with binding buffer A. The flow through from the 
anion exchange column was loaded onto the Ni2+- NTA superflow resin (Qiagen) column 
that was pre-equilibrated with the Binding buffer. The Ni2+-chelating column was washed 
with five column volumes of Wash buffer (40 mM imidazole, pH 7.4 and 500 mM NaCl); 
and the bound enzyme was eluted with two column volumes of elution buffer (30 mM 
HEPES-NaOH, 100 mM imidazole, pH 7.5 and 500 mM NaCl). Fractions with the highest 
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protein yield were pooled together as determined by visualization on a 15% (w/v) SDS-
polyacrylamide gel that was stained with Coomassie Brilliant Blue. An additional 
purification step for TvMGL1p28 was introduced into the procedure, as a result of an 
impurity (ESI observed 45,860±5 Da). Following ammonium sulfate precipitation (as 
described below), the enzyme was suspended in buffer B (50 mM phosphate buffer, 1 M 
NaCl) and resolved on a Superdex 75 chromatography column (GE Healthcare, Piscataway, 
NJ), which was pre-equilibrated with buffer B. The fraction containing the enzyme was 
dialyzed, concentrated and stored at -80°C as described below. 
The enzyme was precipitated with 35% (w/v) ammonium sulphate at 4°C for 15 hr, and 
spun down at 21,000 xg for 30 min at 10ºC. The precipitate was suspended in dialysis buffer 
(1 mL; 100 mM sodium phosphate, 10 mM EDTA, pH 7.2, 200 mM NaCl, 2 mM DTT and 
100 μM PLP), The sample was spun down to remove debris and insoluble enzyme at 15, 000 
xg for 1 min at 22°C. The enzyme was dialyzed (4 x 1 L) against dialysis buffer in a 10k 
MWCO dialysis tubing, over a period of 15 hr at 4°C. The samples were concentrated to 25 
to 30 mg mL-1 with a 10k MWCO centrifuge tube (Sartorius Stedim Biotech & Corning), 
flash frozen in liquid nitrogen and stored at -80°C for future use (stable for more than 5 
months). 
ESI-MS for TvMGL1p28 calculated 44 625.33 Da (N-terminal residues MAH removed) and 
44 127.75 Da (N-terminal residues MAHERMT removed and ammonium ion present), 
observed 44 621±5 Da and 44 128±4 Da. The enzyme was buffered in 10 mM ammonium 
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acetate, pH 7.2, prior to ESI-MS analysis. Total amount of enzyme obtained from 1 L culture 
was 4.5 mg. 
ESI-MS for TvMGL1p28 C113S mutant calculated 44 609.26 Da (N-terminal residues 
MAH removed), observed 44 606±5 Da. The enzyme was buffered in 10 mM ammonium 
acetate, pH 7.2, prior to ESI-MS analysis. Total amount of enzyme obtained from 1 L culture 
was 30 mg. 
 
2.6.6. SDS-Polyacrylamide Gel Electrophoresis 
The protein sample (6 μL total volume) was mixed with a final concentration of 1X loading 
buffer [50 mM Tris-HCl pH 6.8, 1% (v/v) β-mercaptoethanol, 2% (w/v) SDS, 0.1% (w/v) 
bromophenol blue, 10% (v/v) glycerol], and boiled in a water bath for 10 min. The sample 
was loaded onto an SDS polyacrylamide gel and resolved at 200 volts for ~60 min. The 
resolving gel was composed of 14% (w/v) acrylamide mix (acrylamide/bis-acrylamide, 
30:0.8), 380 mM Tris-base pH 8.8, 0.1% (w/v) SDS, 0.1% (w/v) ammonium persulfate, and 
0.04% (v/v) tetramethylethylenediamine (TEMED). The stacking gel was composed of 5% 
(w/v) acrylamide mix, 130 mM Tris-HCl pH 6.8, 0.1% (w/v) SDS, 0.1% (w/v) ammonium 
persulfate, and 0.1% (v/v) TEMED. The protein bands were visualized by staining the gel 
with Coomassie Brilliant Blue. 
The procedures for visualizing the proteins bands on the SDS-polyacrylamide gels  
consisted of: staining solution (0.1% Coomassie Brilliant Blue R, 25% isopropanol, 10% 
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acetic acid) for 1 hr at 21ºC; destaining solution (25% isopropanol, 10% acetic acid) for 15 hr 
at 21ºC. 
 
2.6.7. MBTH Assay Method for Detecting α-Ketobutyrate 
The activity of MGL was monitored by utilizing the MBTH assay as described by Soda et al. 
(1968). Briefly, the reaction mixture (50 μL) for the turnover of methionine consisted of: 60 
mM HEPES-NaOH, pH 8.0, 10 μM PLP, 0.05 to 3.0 mM substrate, and 0.1 μM enzyme. For 
the C113S mutant, the reaction mixture was the same as above except that the final enzyme 
concentration consisted of 1.0 μM TvMGL1p28 C113S. The reaction was initiated with the 
enzyme, proceeded for 2 min at 37°C, and stopped with the addition of 10 μL 12.5% (v/v) 
trichloroacetic acid. The solution was centrifuged at 15 000 xg for 10 min at 4°C, and the 
supernatant (50 μL) was incubated with 140 μL of 1.0 M acetate buffer at pH 5.0 containing 
1.33 mM MBTH at 50°C for 30 min. The amounts of the derivatized samples were 
determined by a standard curve, which consisted of measuring the absorbance at 320 nm with 




CHAPTER 3  
MECHANISTIC STUDIES ON THE ENZYMATIC PROCESSING OF 
FLUORINATED METHIONINE ANALOGS BY TRICHOMONAS 
VAGINALIS L-METHIONINE γ-LYASE 1 
 
3.1. Authors’ Contributions 
The work presented in this chapter was reproduced and revised from Moya et al. (2011). Dr. 
G. Coombs provided the mgl1 gene from Trichomonas vaginalis G3. Dr. R. Smith obtained 
the ESI-MS data for the enzyme and reported compounds. Jan Venne assisted with the 19F-
NMR experiments. Dr. J. Honek obtained the theoretical calculations for the heats of 
formation and the majority of the 19F-NMR chemical shifts. Drs G. Westrop and G. Coombs 
obtained and analyzed the data for the model pathogen, T. vaginalis G3. I. Moya and Dr. J. 
Honek designed the project, discussed the data, and wrote the paper. All other work was 
performed by I. Moya such as syntheses, data analysis and enzyme assays. 
 
3.2. Introduction 
L-Methionine γ-lyase is a pyridoxal-5’-phosphate (PLP)-dependent enzyme, which catalyzes 
the α,γ-elimination reaction of L-methionine (3.1) to produce methanethiol, ammonia and α-
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ketobutyrate (3.2; Figure 3.1) (Lockwood and Coombs, 1991; Tanaka et al., 1977). The 
catalytic α,γ-elimination reaction is driven by the PLP cofactor, as reported by studies using a 
modified PLP derivative that mimics the catalytic reaction mechanism of the enzyme 
(Johnston et al., 1981; Karube and Matsushima, 1977). The reaction rate of the catalytic 
cofactor is enhanced by the environment of the enzyme as a result of conformational strain 
imposed on the Schiff-base and planarity of external aldimine linkage, and proximity effects 
of catalytic side chains (Dubnovitsky et al., 2005; Hayashi et al., 2003; Zabinski and Toney, 
2001). Thus, MGL provides an appropriate environment for the PLP cofactor to facilitate the 




Figure 3.1. Schematic representation of the reaction catalyzed by the PLP-
dependent enzyme MGL. 
 
3.3. Pyridoxal Model Systems of Enzymatic Catalytic Reactions 
The vitamin B6 cofactor, pyridoxal, is known to catalyze racemization, decarboxylation, 
transamination, elimination and substitution reactions of amino acids; and believed to mimic 
the mechanism of PLP-dependent enzyme-catalyzed reactions (Figure 3.2) (Metzler et al., 
1954a). The initial steps for these reactions involve the formation of an aldimine linkage with 




conjugated system from the amino acid to the pyridine ring of pyridoxal, and favours the 
labilization of the α-hydrogen atom of the amino acid to produce the ketimine-quinoid 
intermediate (3.4; Figure 3.2) (Metzler et al., 1954a). 
For racemization of the amino acid by pyridoxal, the proton is removed and then 
reintroduced at the opposite face of the Cα atom, which is favoured at pH 10 (Figure 3.2a) 
(Olivard et al., 1952). Transamination is favoured at pH 5, where the C4’ atom of the 
aldimine is protonated followed by hydrolysis of the ketimine to yield pyridoxamine (3.6) 
and the α-ketoester (3.7; Figure 3.2f) (Matsuo, 1957; Olivard et al., 1952). Elimination of the 
amino acid side chain requires reorientation of the side chain, antiparallel to the planar 
conjugated system (Figure 3.2b) (Christen and Mehta, 2001). This has been observed for the 
splitting of threonine and serine to produce glycine, and their respective acetaldehyde and 
aldehyde leaving groups (Metzler et al., 1954b). Elimination reaction of a β-substituted 
electron attracting group from the side chain of an amino acid, such as hydroxyl and thiol 
functional groups, involves the deprotonation of the Cα atom and a shift of electrons in the 
conjugated system to produce an imino acrylate (3.5; Figure 3.2d) (Metzler and Snell, 1952; 
Thomas et al., 1968). Elimination of a γ-substituted electron attracting group from an amino 
acid, such as hydroxyl and thiol functional group, involves the deprotonation of the Cβ atom 
and a shift of electrons in the conjugated system (Figure 3.2e) (Metzler et al., 1954a). 
Substitutions at the Cα atom of glycine occurs readily for acetaldehyde and aldehyde, which 
















































































































Figure 3.2. The various nonenzymatic catalytic reactions on an amino acid by 
pyridoxal. 
Pyridoxal catalysis of various reactions on an amino acid by a) racemization of the Cα 
atom, b) elimination of the amino acid side chain (where R = CH3(CO)H or 
formaldehyde), c) decarboxylation at the Cα atom, d) elimination of the electron 
attracting group at the Cβ atom (where X = thiol or hydroxy functional group), e) 
elimination of the electron attracting group at the Cγ atom (where X = thiol or 
hydroxy functional group) and f) transamination. Adapted from Metzler et al. 







at the Cβ atom do not proceed readily, as reported for the non-enzymatic synthesis of 
tryptophan from serine and indole (Metzler et al., 1954a), and substitutions at the Cγ atom are 
reported for a modified pyridoxal cofactor (Karube and Matsushima, 1977). For amino acids 
to undergo decarboxylation, the carboxylate group is reorientated antiparallel to the plane of 
the conjugated system, which may proceed in the absence of metal ions (Figure 3.2c) 
(Kalyankar and Snell, 1962; Zabinski and Toney, 2001). Thus, pyridoxal may catalyze 
several types of reactions depending on the functional groups present and the reaction 
conditions. 
 
3.4. Processing of Fluorinated Methionine Analogs by PLP-dependent Enzymes 
Previous studies have suggested that the methionine analog L-trifluoromethionine (TFM; 3.8) 
may act as a potential prodrug in organisms that express γ-eliminating enzymes, such as 
MGL (Alston and Bright, 1983). The processing of TFM is hypothesized to produce 
trifluoromethanethiol, which spontaneously decomposes to thiocarbonyl difluoride (3.15), a 
chemically reactive molecule that results in cellular toxicity. The bioactivity of TFM was 
later confirmed in antimicrobial screens against microorganisms that contain MGL, such as 
Entamoeba histolytica, T. vaginalis, and Porphyromonas gingivalis (Coombs and Mottram, 
2001; Tokoro et al., 2003; Yoshimura et al., 2002). 
Previous investigations on the effects of fluorination on methionine analog biochemistry 
indicated alterations in its electronic, as well as steric properties when incorporated within 
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enzymes (Duewel et al., 2001) (and references therein). Therefore, it was of interest to 
evaluate the effects of increasing fluorination at the thiomethyl moiety of the methionine 
analog on the efficiency of enzymatic processing by MGL, and the effect of fluorination on 
antiparasitic activity. For example, the processing of the analog, DFM would likely act as a 
thioformylating agent. Thus, it would be of interest to determine if this type of conversion 
could also be lethal to a parasite containing MGL, which may lead to future modulation of 
the activity of the fluorinated compound by introducing other moieties into the fluorinated 
methanethiol group. 
To date, the production of a thioacylating agent upon the processing of TFM and DFM by 
MGL has not been experimentally confirmed. To identify these very reactive agents, the 
fluorinated methionine analogs were studied with the recombinant MGL enzyme as well as a 
model pyridoxal system, which is known to mimic the γ-elimination of the TvMGL1 enzyme 
itself (Johnston et al., 1981; Karube and Matsushima, 1977). To investigate the differences in 
cytotoxicity between TFM and DFM, the levels of cell growth inhibition for the two 
fluorinated methionine analogs were examined with Escherichia coli expressing TvMGL1 as 





3.5.1. Detecting the Products from the Enzymatic Processing of the Fluorinated 
Methionine Analogs 
The recombinant TvMGL1 was previously cloned into a pQE vector possessing an inducible 
promoter for overexpression, and with a hexahistidine tag incorporated at the C-terminus of 
the enzyme (McKie et al., 1998). The enzyme was overexpressed in E. coli and purified by a 
Ni2+-chelating resin. The syntheses of DFM (3.9) and TFM (3.8) from L-homocystine (3.7; 






Figure 3.3. Syntheses of TFM (3.8) and DFM (3.9). 
a) Sodium metal, liquid ammonia, -78°C, 20 min; b) potassium t-butoxide, 
iodotrifluoromethane, ethanol, 21°C, 15 hr with photolysis; c) potassium t-butoxide, 







The processing of DFM and TFM by the recombinant enzyme was monitored by 1H 
decoupled 19F-NMR and 19F-NMR, respectively, for changes in the chemical shift of the 
fluorine nuclei of the compounds, as described previously for the processing of TFM by 
cystathionase (a γ-eliminating PLP-dependent enzyme) (Alston and Bright, 1983). A total of 
144 scans were taken with a sweep width of +100 to -125 ppm, in order to cover the region 
where the calculated and experimental fluorine signals were expected to appear (Table 3.1). 
In the negative control experiments (incubation without enzyme), a 19F NMR resonance 
signal was observed at -41.4 ppm, which corresponded to the fluorine nuclei in TFM (Figure 
3.4a), and in a separate experiment, at -93.3 ppm for the fluorine nuclei in DFM (Figure 
3.4c). Upon the addition of the enzyme, a second 19F NMR resonance was observed at -119.8 
ppm for both TFM and DFM samples (Figure 3.4 b and d), which coincided with the 
chemical shift of the fluoride ion under similar conditions (Figure 3.4e). All of the 19F-NMR 
chemical shifts in the current experiments were consistent with the literature values for TFM, 
DFM and the fluoride ion previously reported (Duewel et al., 1997; Gerken et al., 2002; 
Soloshonok et al., 1992; Vaughan et al., 1999). 
No other 19F-NMR chemical shifts were observed for the intermediates proposed for the 
enzymatic processing of TFM and DFM, during the timeframe and sweep width of the 
experiments. The reported literature values for the 19F-NMR chemical shifts for the fluorine 
nuclei of trifluoromethanethiol (3.16) and thiocarbonyl difluoride (3.15; the proposed 





Figure 3.4. 19F-NMR spectra for the processing of TFM and DFM by TvMGL1 
(externally locked with CFCl3). 
The processing of TFM (δ: -41.4 ppm) in a) the absence and b) the presence of the 
enzyme; the processing of DFM (δ: -93.3 ppm) in c) the absence and d) the presence 
of the enzyme; and e) the control, 2.0 mM sodium fluoride (δ: -119.8 ppm).
a.  + Enzyme 
b.  t = 10 min 
c.  - Enzyme 
d.  t = 10 min 




CFCl3 (Table 3.1) (Adams et al., 1998; Haas and Wanzke, 1987). However, there are no 
known reports of the 19F-NMR chemical shifts for the fluorine nuclei of difluoromethanethiol 
(3.15) and thioformyl fluoride (3.19), the proposed products in the enzymatic processing of 
DFM. 
The accuracy of the theoretical 19F-NMR chemical shifts was higher for the geometry 
optimized DFT (rms error 8.5 ppm) and MP2 (rms error 10.8 ppm) basis sets than the 
geometry optimized HFT basis set (rms error 19.5 ppm) (Table 3.1). Overall, the basis sets 
used for the theoretical calculations were in good agreement with the experimental values, 
even though solvation effects were not taken into account. Thus, the scanning region selected 
for the 19F NMR experiment was likely appropriate for monitoring the expected fluorine 
nuclei of the nonenzymatic decomposition products, generated from the enzymatic reactions. 
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3.10 CFCl3 0.0 (12.3) 0.0 (199.9) 0.0 (179.2) 0.0 (REF) 
3.11 CH3C(O)F 51.7 36 56.2 50
a 
3.12 FC(O)OCH3 9.7 4.1 -30.3 -18.7
b 
3.13 CF2HSCH3 -91.5 -103 -107.5 -97.3
c 
3.14 CF3SCH3 -34.6 -48.1 -57.8 -45
d 
3.15 CHF2SH -74.6 -84.5 -87.2  
3.16 CF3SH -22.8 -35.4 -44 -31.4
e 
3.17 HC(O)F 51.3 36.6 45.6 42.8f 
3.18 FC(O)F 5.4 -34 -28.2 -23g 
3.19 HC(S)F 88.3 70.7 98.1  
3.20 FC(S)F 69.9 31.1 44.2 41.2h 
3.21 FC(S)OH 59.7 40.8 49.0  
3.22 FC(S)OCH3 70.2 28.8 36.8  
3.23 FC(S)N(CH3)2 39.8 10.9 14.9 13.37
i 
3.24 FC(S)NC4H8O 37.9 3.0 5.5  
The experimental values are from: aKirij et al. (2000), bAppelman et al. (1985) and Bock et al. (1968), 
cLange and Shreeve (1985), dYu et al. (1974), eHaas and Wanzke (1987), fde Rege et al. (1997), 
gDowns (1962), and hAdams et al. (1998), iTyrra (2001). 
HFT: Hartree-Fock Theory, HFT/6-311+G(d,p)//B3LYP/6-31G(d) gauge including atomic orbitals 
(GIAO); MP2: Møeller-Plesset theory, MP2/6-311++G(2d,p)//B3LYP/6-311++G(2d,p) GIAO; DFT: 
density functional theory, B3LYP/6-31+G(df,p)//B3LYP/6-31+G(df,p) GIAO. HFT calculations 
utilized Spartan ’08 software (Wavefunction Inc., Irvine, CA, USA) (Shao et al., 2006). MP2 and DFT 
level GIAO calculations were carried out utilizing Gaussian 03 and Gaussview v3.0.9 for structure 
drawing and calculation setup (Frisch et al., 2003a; Frisch et al., 2003b). The theoretically calculated 
chemical shifts of the compounds were referenced to the theoretically calculated chemical shielding 




To examine whether the decomposition of the thioacylating agents were 
thermodynamically favorable, the heats of formation were calculated using T1 and G3 (MP2) 
high level thermochemical methods (Curtiss et al., 1999; Ohlinger et al., 2009). The 
nucleophiles methylamine and water were chosen for the calculations as a model for the ε-
amines in lysine found on the surface of the homodimer (45 out of a total 52 lysines; PDB 
code1E5F, unpublished crystal structure) and the water present in the reaction mixture, 
respectively. Analyses of the theoretical calculations indicated that the heats of formation for 
the reactions between the thioacylating agent and the nucleophiles (methylamine or water) 
were thermodynamically extremely favorable (Table 3.2). 
To examine the stabilities of the methylmercaptan products generated from the enzymatic 
reaction, the theoretical pKa values of the thiols were calculated using previously reported 
computational methodologies (Klicic et al., 2002). The pKa values were found to decrease as 
follows: methanethiol (pKa 10.6) > difluoromethanethiol (pKa 5.2) > trifluoromethanethiol 
(pKa 2.8) which were consistent with the previously reported trend for their theoretical gas 
phase acidities (Burk et al., 2000). Thus, analysis of the predicted pKa values indicated that 
the thiolate forms of trifluoromethanethiol and difluoromethanethiol would be the 




Table 3.2. T1 and G3(MP2) enthalpies of formation at 298 K for the reaction between 
the thioacylating agents and water or methylamine.  
 
Spartan ‘08 software (Wavefunction Inc., California, USA) was utilized for structure drawing and 
thermochemical calculations using the default protocols for the T1 and G3(MP2) thermochemical 
recipes as employed in this program. Choice of the exact structures (e.g., syn versus anti) utilized in 
these calculations were made based on utilizing the lowest energy structures found from geometry 
optimization calculations at the B3LYP/6-31G* level to determine the starting geometries for the 
thermochemical recipes (Shao et al., 2006). 
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The difficulty in confirming the existence of the thioacylating agent, produced from the 
enzymatic processing of the fluorinated methionine analogs, was the heterogeneity of 
potential nucleophiles within the reaction mixture, such as buffer, water and enzyme. To trap 
the thioacylating products, the complexity of the reaction was reduced by using a PLP model 
system (Figure 3.5); thus, avoiding protein and extra buffers. It has been previously 
demonstrated that N-methylpyridoxal chloride (MPAL, 3.29) in a KOH/methanol solution 
can mechanistically mimic the γ-elimination reaction catalyzed by the intact MGL enzyme 
(Johnston et al., 1981; Karube and Matsushima, 1977). It was hypothesized that the 
fluorinated methionine analogs would be processed by MPAL to produce the reactive 
thioacylating agents (Figure 3.5 a and b). Morpholine (3.25) was selected as the trapping 
agent in this study because its alkyl groups are restrained, and it is a strong nucleophilic 
amine (Moltzen et al., 1987). The synthesis of MPAL was adapted according to the methods 
reported by Heyl (1951) and Johnston (1981), and the syntheses of the authentic reference 
standards for the trapped thioacylating agents were followed according to previously reported 
procedures (Beerheide et al., 2000; Mills, 1986) (Figure 3.5). 
The conditions for the PLP model system were followed according to the methods 
previously described by Karube and Matushima (1977) for normal substrates. The reaction 
mixture containing synthetic MPAL and the fluorinated methionine analogs were treated 
with morpholine. Any reaction products trapped by morpholine were extracted by washing 
the aqueous reaction mixture with ethyl acetate or CHCl3. The major products for the DFM 
and TFM reactions were consistent with the authentic reference standards (4-thioformyl-





Figure 3.5. The proposed reaction for the production of the thioacylating agents using a model pyridoxal system, and 
syntheses of MPAL and authentic reference standards. 
Catalytic processing of TFM (3.8) and DFM (3.9) by MPAL and generation of a) thiocarbonyl difluoride when X = F (3.20) 
and b) thioformyl fluoride when X = H (3.19). The capture of thiocarbonyl difluoride and thioformyl fluoride with morpholine 
(3.25) to afford 4,4’-thiocarbonyldimorpholine (3.27) and 4-thioformylmorpholine (3.26), respectively. Synthesis of MPAL 
(3.29) from pyridoxal chloride (3.28): c) methanol; d) iodomethane, benzene, 21°C, 24 hr; e) silver chloride, 21°C, 2 hr; f) 
dilute HCl. Synthesis of 4,4’-thiocarbonyldimorpholine (3.27) from 1,1’-thiocarbonyldiimidazole (3.30): g) triethylamine, 
methylene chloride, 4°C to 21°C, 4 hr. Synthesis of 4-thioformylmorpholine (3.26) from N,N’-dimethyl thioformamide (3.31): 








3.23.8: X = F 
3.9: X = H 
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Rf values by TLC (see Materials and Methods), 
1H-NMR spectroscopic properties (Figure 
3.6) and their electrospray mass spectra (Figure 3.7). The amount of product trapped was 
50% for thiocarbonyl fluoride and 16% for thioformyl fluoride as estimated by 1H-NMR 
spectroscopy (Table 3.3). Thus, the intermediates trapped from the processing of DFM and 
TFM by MPAL were thioformyl fluoride and thiocarbonyl difluoride, respectively. 
 
 
Table 3.3.  Amount of thioacylating agent trapped and fluoride produced from the 







[Substrate]i 1.00 1.00 
19F-NMR 
[Substrate]f 0.15 0.29 
Fluoride 2.45 1.66 
1H-NMR 
Trapped 0.50 0.16 
Samples were locked with D2O for 1H-NMR experiment and externally locked with CFCl3 for 
19F-
NMR experiment using a 300 MHz NMR (Bruker) spectrometer. [Substrate]i is the initial concentration 





Figure 3.6. 1H-NMR spectra of the extracted compounds from the TFM and 
DFM PLP model reactions. 
The NMR spectra (locked with CDCl3) for a) the extracted compound from the TFM 
reaction and b) the authentic reference standard, 4,4’-thiocarbonyldimorpholine (δ: 
3.59, 3.72 ppm). The NMR spectra (locked with C6D6) for c) the extracted compound 
from the DFM reaction and d) the authentic reference standard, 4-
thioformylmorpholine (δ: 2.33, 2.80, 3.03, 3.61, 8.76 ppm). The likely impurity in the 
spectrum for TFM PLP model reaction is ethyl acetate (δ: 4.12 ppm; q), and for DFM 





Figure 3.7. ESI-MS spectra of the extracted compounds from the TFM and DFM 
PLP model reaction. 
The trapped compound from a) the DFM reaction had a mass of 132.04 Da [M+H]+ 
that corresponded to the expected mass of 4-thioformylmorpholine, and b) the TFM 
reaction had a mass of 217.11 Da [M+H]+ that corresponded to the expected mass of 
4,4’-thiocarbonyldimorpholine. Samples were diluted with ACN/H2O/formic acid 
(1:1:0.004). Possible impurities for the TFM reaction include N-methylpyridoxal 
(182.08 Da, [M]+), N-methylpyridoxal monomethylacetal (196.10 Da, [M]+) and 
trifluoromethionine (204.04 Da, [M+H]+). Possible impurities for the DFM reaction 
include N-methylpyridoxal monomethylacetal (196.10 Da, [M]+) and 
difluoromethionine (185.14, [M+H]+). 
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3.5.2. Monitoring the Intermediates Produced from the Processing of TFM and DFM by 
MPAL 
In the PLP model system, 19F-NMR spectroscopy was used to identify the fluorine nuclei of 
the unstable intermediates produced from the processing of TFM and DFM by the modified 
cofactor, MPAL. Initially, no intermediates were detected by 19F-NMR when maintaining the 
reaction conditions constant as previously described in the paper. The likely problems for the 
negative results were as follows: 1) formation of crystals as the reaction proceeded overtime 
and consequently a lack of a fluorine signal for fluoride anion, 2) morpholine and basic 
methanol may have quenched the signal of the intermediates, 3) and a low amount of catalyst 
to initiate the reaction. Despite fluoride anion crystallizing out of solution, the system was 
not supplemented with water because the thioacylating agents were predicted to undergo 
hydrolysis. The concentration of nucleophiles within the system was reduced to 1.0 mM 
KOH and 90 mM morpholine, and the mixture was subsequently diluted to 30% (v/v) with 
ethyl acetate. Finally, the amount of catalyst was increased to 1 mM in order for MPAL to 
process more DFM and TFM. During the time frame of the 19F-NMR experiment, two 
fluorine signals with a chemical shift of +11.6 ppm and -41.4 ppm were observed for the 
TFM sample after 2.5 hr (Figure 3.8). The chemical shift at -41.4 ppm coincided with the 
authentic reference standard TMF, while +11.6 ppm coincided with the theoretically 
calculated and experimentally reported value of N,N’-dimethyl thiocarbamoyl fluoride (3.23) 
(Tyrra, 2001), and very close to the 19F-NMR chemical shift calculated for the more 
computationally demanding morpholine adduct (3.24; Table 3.1). Thus, the 19F-NMR 
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chemical shift of -41.4 ppm corresponded to TFM, while the chemical shift of +11.6 ppm 
likely corresponded to 4-morpholino thiocarbonyl fluoride (3.24), a chemical analog of N,N’-
dimethyl thiocarbamoyl fluoride (3.23; Table 3.1). No other fluorine signals were observed 
during the timeframe of the experiment for the processing of either TFM or DFM in the 
methanol-ethyl acetate mixture (3:7 v/v ratio). The lack of any other fluorine signal may have 
resulted from the extensive crystallization that occurred upon the addition of ethyl acetate, 
and potential nucleophiles predicted to react with the thioacylating agent. 
 
3.5.3. Kinetic Parameters for the Enzymatic Processing of the Fluorinated Methionine 
Analogs 
The activity of the enzyme was initially assayed spectrophotometrically at 320 nm after 
incubation of the enzymatic products with the derivatizing agent, 3-methyl-2-
benzothiazalone hydrazone hydrochloride (MBTH) as previously described (Soda et al., 
1969). However, the kinetic parameters of TvMGL1 upon processing of DFM at high 
concentrations (>1.2 mM) could not be accurately obtained due to extensive precipitation 
upon inclusion of the derivatization reagent (data not shown). To circumvent this issue, 
another approach was developed (see below) as we hypothesized that the derivatizing agent 








Figure 3.8. 19F-NMR spectrum for the processing of TFM by MPAL in a solution 
of methanol-ethyl acetate (externally locked with CFCl3). 
The processing of TFM (δ: -41.4 ppm) at given time intervals and the appearance of a 
measurable intermediate at 2.5 hr (δ: +11.6 ppm; 364 scans). 
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A lactate dehydrogenase (LDH) coupled assay was developed in order to obtain the 
kinetic parameters for the processing of methionine and its fluorinated analogs by TvMGL1, 
similar to the method described for the γ-lyase activity of cystathionine γ-synthase (Holbrook 
et al., 1990). The product, α-ketobutyrate produced by the activity of TvMGL1, was coupled 
to the oxidation of NADH by LDH to produce 2-hydroxybutyrate, and the resulting loss in 
NADH was monitored spectrophotometrically at 340 nm (Figure 3.9a). The catalytic 
turnover rate constant (kcat) for TvMGL1 was found to increase as follows: methionine < 
DFM < TFM; while the Km value was found to increase as follows: DFM < TFM < 
methionine (Table 3.4; Figure 3.9 b and c). Analysis of the enzyme’s catalytic efficiency 
indicated that DFM was processed more efficiently than TFM and methionine (Table 3.4).  
 
 
Table 3.4. The kinetic parameters of TvMGL1 for methionine and its analogs. 
The standard errors were obtained from three independent experiments. 
 
Substrate Km kcat kcat/Km 
 mM min-1 M-1 s-1 
Methionine 0.193 ± 0.014 403 ± 12 34.8 x103 
DFM 0.025 ± 0.003 498 ± 5 332 x103 




Figure 3.9. Michaelis-Menten kinetics and initial rates for the LDH coupled 
assay of TvMGL1 processing methionine and its fluorinated analogs. 
a) The reaction overview of MGL and the LDH coupled reaction. b) The kinetic 
parameters for the turnover rate of methionine (squares), DFM (triangles) and TFM 
(circles) with standard errors from three independent experiments. c) The initial rates 
of the enzyme for 1.0 mM of substrate: methionine (squares), DFM (triangles) and 
TFM (circles) with standard error from three independent experiments. 
 
3.5.4. Possible Modes of Inhibition of TvMGL1 
The evidence presented so far suggested that the processing of fluorinated methionine 
analogs would generate thioacylating agents that have the potential to react with cellular 
nucleophiles as well as covalently modifying protein. For example, the processing of TFM 
by TvMGL1 would likely generate thiocarbonyl difluoride, which has the potential to 
thiocarbamoylate an amine or cross-link another amine on the surface of the protein (Figure 





fluoride, which has the potential to thioformylate only a single amine on the surface of the 
protein since only one fluorine atom is present (Figure 3.10b). Either one of the two 
scenarios might interfere with the activity of the enzyme or inactivate it. The possibility of 
this occurring in the LDH coupled assay was uncertain, because product inhibition might led 





Figure 3.10. The proposed reaction scheme for the production of the 
thioacylating agents upon processing of the fluorinated methionine analogs by 
TvMGL1. 
a) Thiocarbonyl difluoride (3.20) generated from the enzymatic processing of 
trifluoromethionine (3.8), and b) thioformyl fluoride (3.19) generated from the 
enzymatic processing of difluoromethionine (3.9), and potential chemical 
modification(s). c) The proposed cross-linking reaction for thioformyl fluoride (3.19) 
with a primary amine to afford an amidine (3.32). 
 
3.32
3.9: X = F 





Evidence for protein modification was examined by the extent of cross-linking of MGL, 
since the processing of DFM by MGL might lead to the sequential reaction of thioformyl 
fluoride with two primary amines. For this to occur, the sulfur atom in thioformyl fluoride 
would have to be eliminated as hydrogen sulfide upon reacting with two primary amines 
(Figure 3.10c). Precedent for this alternative reaction has indeed been observed for the 
decomposition of a thioformamide to an amidine (3.32; Figure 3.10) as a result of an excess 
of a primary amine (Moltzen et al., 1987). To examine this possibility, an intermolecular 
cross-linking experiment was performed by incubating TvMGL1 with the substrate of choice 
(either methionine plus formaldehyde, DFM or TFM) for 30 min at 30°C. Aliquots for each 
of the reactions were loaded onto a SDS-polyacrylamide gel in order to visualize any changes 
in molecular weight of TvMGL1. The positive controls, formaldehyde and TFM (when 
processed by MGL) were selected for the experiment because they are known cross-linking 
agents (Metz et al., 2004; Sato et al., 2008). Incubation of TvMGL1 with formaldehyde, 
TFM or DFM followed by an SDS-PAGE analysis revealed the presence of higher molecular 
weight proteins than expected for TvMGL1 (Figure 3.11). Based on the integrated density 
values, the concentrations for the higher molecular weight proteins (~88 kDa) were 1.99 μM, 
199 nM and 225 nM for the samples treated with either formaldehyde, TFM and DFM, 
respectively. Importantly, samples containing methionine in place of the potential prodrugs 
resulted in no observable changes in the molecular weight of TvMGL1.  
During the course of the cross-linking experiments, the appearance of a lower molecular 
weight band (~32 kDa) was observed for the samples treated with DFM and TFM (Figure 
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3.11), as reported in a cross-linking study for the processing of TFM by EhMGL (Sato et al., 
2008). However, further analysis of the cleavage product was not possible, as the protein 
fragment was either lost or failed to resolve during the subsequent chromatographic 
purification steps (i.e., size exclusion, ion exchange and C8 chromatographic steps). 
To provide further evidence that the thioacylating agents may lead to intermolecular cross-
linking of the enzyme, attempts were made to reduce cross-linking by either inhibiting the 
enzyme or by scavenging any reactive intermediates with a nucleophilic compound included 
in the reaction buffer. Cysteamine was selected as a suitable candidate for this experiment 
because it is known to efficiently react with carbonyl groups (Miyake and Shibamoto, 1995) 
and with the free or bound PLP to produce a thiazolidine (De Marco and Bognolo, 1962). 
Therefore, protection against cross-linking might be achieved when cysteamine reacts with 
the electrophilic thioacylating agent or inactivates the enzyme upon sequestering PLP. Upon 
visualization of the SDS-polyacrylamide gel, the addition of cysteamine reduced the extent 
of intermolecular cross-linking for the samples treated with formaldehyde, TFM and DFM 
(Figure 3.11). These results strongly support the notion that the processing of TFM and DFM 
by TvMGL1 could produce a relatively low amount of cross-linked proteins as well, under 





Figure 3.11. An SDS-polyacrylamide gel analysis of the intermolecular cross-
linking of TvMGL1 with various compounds, and its inhibition with cysteamine 
in vitro. 
The samples were loaded onto the SDS-polyacrylamide gel as follows: low molecular 
weight marker; high molecular weight marker; methionine (MET); methionine and 
formaldehyde (FA); methionine, formaldehyde and cysteamine (CA), TFM; TFM and 
cysteamine; DFM; and DFM and cysteamine. 
 
3.5.5. Cellular toxicity of the Fluorinated Methionine Analogs in Organisms that Express 
TvMGL1 
To examine the differences in the cytotoxic effects of TFM and DFM, the level of cell 
growth inhibition for an E. coli model system that expresses TvMGL1 was measured 
spectrophotometrically by following an earlier reported procedure (Coombs and Mottram, 
2001). For this experiment, the mgl1 gene from T. vaginalis was cloned into an expression 
vector and overexpressed in E. coli. The transformed cells with the plasmid containing the 
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mgl1 gene were incubated with various concentrations of the fluorinated analogs, and the 
level of inhibition was measured relative to negative control (i.e., cells untreated with the 
compound). The positive controls were conducted in the presence of either ampicillin and 
NaF as inhibitors since ampicillin is known to inhibit bacterial growth, and fluoride ion can 
inhibit certain enzymes such as acid phosphatase (von Hofsten, 1961a). As expected, 
ampicillin and an excess of NaF inhibited cell growth, while no effects were observed upon 
treatment with methionine (Table 3.5; Figure 3.12 b and a respectively). When the cells were 
treated with DFM and TFM, inhibition of cell growth was observed (an EC50 value of ~20 
μM for both compounds; Table 3.5; Figure 3.12 c and d respectively).  
The negative control cells (lacking the mgl1 gene) were examined in order to correlate cell 
growth inhibition with the activation of the fluorinated methionine analogs by TvMGL1. Cell 
growth was inhibited when the cells were treated with either ampicillin or NaF, but not with 
DFM, TFM or methionine (Figure 3.12f). Overall, the fluorinated methionine analogs did not 
inhibit cell growth for E. coli cells lacking TvMGL1. 
To determine if DFM was toxic to organisms that endogenously express MGL, the growth 
inhibitory effects of DFM (performed by our collaborators Westrop and Coombs, University 
Strathclyde, Glasgow, UK) was tested on T. vaginalis, an anaerobic pathogen that is known 
to contain high levels of MGL activity (Coombs and Mottram, 2001; Lockwood and 
Coombs, 1991). DFM was found to be active against this pathogen, approximately 20-fold 
less potent than the clinically approved drug, metronidazole (Table 3.5; Figure 3.12 e); and 
2-fold less potent than the EC50 value of DFM obtained in the E. coli model (Table 3.5). 
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Assuming that the transporter efflux between TFM and DFM in T. vaginalis did not 
significantly differ from the E. coli model, the growth inhibitory effects should reflect the 
potency of the compound between the two model organisms. 
 
Table 3.5.  The EC50 values of various compounds for E. coli cells expressing 






E. coli model  
MET 0 
TFM 21.7 ± 0.7 
DFM 24.0 ± 0.9 
Amp 0.498 ± 0.009 
NaF (19.3 ± 1.2) x103
  
T. vaginalis  
Metronidazole 2.12 ± 6.08 
DFM 40.1 ± 6.3 
TFM* ND 
The standard errors for the E. coli model and T. vaginalis were obtained from three and two 
independent experiments, respectively. *Note, the MIC for TFM was reported to be 24.6 μM for a 24 h 













Figure 3.12. The growth inhibition of E. coli cells overexpressing MGL1 and 
control E. coli cells, and the growth response of T. vaginalis. 
The E. coli cells overexpressing MGL1 were treated with a) L-methionine, b) 
ampicillin (triangles) and NaF (squares), c) DFM and d) TFM with standard error 
from three independent experiments. The EC50 value for ampicillin was similar to the 
value reported for E. coli CCM 3988 (Jantova et al., 1999). T. vaginalis were treated 
with e) metronidazole (triangles) and DFM (squares) with standard error from two 
independent experiments. The growth inhibition of E. coli cells that lacked TvMGL1 
in the presence of the following compounds (left to right): 71 μM L-methionine, 71 
μM DFM, 71 μM TFM, 2 μM ampicillin (AMP) and 52 mM NaF with standard errors 
from three independent experiments. 
 
3.6. Discussion 
19F-NMR studies demonstrated that TvMGL1 rapidly processed DFM as the 19F-NMR 
signals rapidly disappeared in the presence of enzyme (Figure 3.4d). The proposed 
intermediates, difluoromethanethiol and thioformyl fluoride were not observed by 19F-NMR, 
since the species were likely too short lived for the observable time frame of the experiments. 
Similar results were observed for the processing of TFM by TvMGL1, in which the fluorine 
nuclei signals were not observed for trifluoromethanethiol and thiocarbonyl difluoride by 
19F-NMR spectrometry. In general, the processing of DFM and TFM by TvMGL1 was 
supported by the additional resonance that coincided with the fluorine nucleus of the fluoride 
ion, which was the final decomposition product. 
19F-NMR studies on the PLP model system indicated a lack of a fluorine signal for the 
proposed fluorinated mercaptans and thioacylating agents produced from the processing of 
DFM and TFM by MPAL (Figure 3.8). Extending the model to the intact enzyme, the results 
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would suggest that the intermediates were extremely short lived and were undetectable under 
the basic methanol reaction conditions, and consistent with the 19F-NMR results for the intact 
enzyme, TvMGL1 (Figure 3.6). The detection of the likely intermediate, 4-morpholino 
thiocarbonyl fluoride suggested that the thioacylating agent, thiocarbonyl difluoride was 
generated from the processing of TFM by MPAL as well as the intact enzyme, TvMGL1 
(Figure 3.8). 
The notion that the above reactive intermediates were too short lived to be observed was 
consistent with the thiols existing as thiolates based on the calculated pKa values, and the 
anionic hyperconjugation and electrostatic effects that favour their decomposition to the 
thioacylating agents (Schneider et al., 1995). The observed reactivity of the thioacylating 
agents supported the calculated heats of reaction (Table 3.2), in which nucleophilic attack on 
the thioacylating agents by water or amines is a thermodynamically favourable process. This 
would explain the production of fluoride ion as observed by 19F-NMR (Figure 3.4), and 
previous reports on the instability of trifluoromethanethiolate and thiocarbonyl difluoride 
(Alston and Bright, 1983; Coombs et al., 2004; Jellinek, 1959). 
The incompatibility of the derivatizing agent, MBTH with DFM in the presence of 
TvMGL1 led to the development of an LDH coupled assay. For the turnover of methionine 
by TvMGL1, the kinetic parameters obtained from the assay were consistent with the values 
obtained by utilizing the MBTH assay (McKie et al., 1998). For the processing of TFM, the 
kcat for TvMGL1 was ~6-fold greater than the previously reported activity of a MGL1/MGL2 
mixture from T. vaginalis, and with similar Km values, which were obtained by utilizing the 
 
79 
MBTH assay method (Coombs and Mottram, 2001). These differences in catalytic activity 
were likely to have arisen from the differences in kinetic parameters between the two MGL 
isozymes as reported for the turnover of methionine (McKie et al., 1998). Additionally, its 
catalytic activity was comparable to E. histolytica EhMGL 2 enzyme, and its Km value was 
similar to EhMGL 1, both of which were obtained utilizing the MBTH method (Sato et al., 
2008). For the processing of DFM by an MGL enzyme, to our knowledge, this is the first 
report of its kinetic values. 
The correlation between increasing fluorination of the compound and increasing rate of 
reaction (i.e., TFM > DFM > methionine) would suggest that the inductive effect and anionic 
hyperconjugation of the fluorinated methyl thiolates improve its leaving ability. This is 
consistent with the idea that the C-S bond cleavage is a rate determining step of the enzyme 
as reported by a 1H-NMR study on MGL from Pseudomonas putida (Esaki et al., 1977). 
The activity of the enzyme does not appear to be compromised as a result of the increase in 
volume for each fluorine atom in the fluorinated methionine analogs (19% for the 
trifluoromethanethio group and 12% for the difluoromethanethio group relative to the 
methanethio group) (Houston et al., 1997). Additionally, the enzyme appears to favour the 
enzyme-substrate complex for DFM over methionine as indicated by the 10-fold difference 
in Km value, despite its bulky substitution. On the other hand, TFM has in a similar Km value 
as methionine, which suggests that the bulkier substitution do not enhance the enzyme-
substrate complex (Table 3.4). Overall, the processing of DFM by TvMGL1 is catalytically 
more efficient than TFM and methionine (Table 3.4). 
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The processing of the fluorinated methionine analogs by TvMGL1 likely inactivated some 
molecules of the enzyme as a result of covalent modification. This was supported by a 
similar finding for the processing of TFM by MGL from E. histolytica (EhMGL) (Sato et al., 
2008), intermolecular cross-linking of TvMGL1 (Figure 3.11), the thioacylating agent 
reacting with a restrained secondary amine in the PLP model system (Figure 3.6 and Figure 
3.7), and the thermodynamically favourable process of the thioacylating agent reacting with 
nucleophiles such as the side chains of lysine residues on the surface of the protein or water 
(Table 3.2). It is tempting to extrapolate the data for the amount of cross-linked dimers to 
explain the apparent decrease in the initial rate for the LDH coupled assay after 60 sec, i.e., 
6.6 nM and 7.5 nM of cross-linked homodimeric enzymes for the enzymatic processing of 
TFM and DFM, respectively (Figure 3.9c). However, caution should be exercised when 
applying quantitative values to other experiments such as the LDH coupled assay and the cell 
inhibition assay, because of differences in protein concentration, quantities of cross-linking 
agent and potential side reactions. More importantly, the rate of protein cross-linking is 
expected to be influenced by a variety of factors such as proximity effects, number of 
collisions, amount of cross-linking agent and competing side reactions (e.g., dimer or 
monomer form of MGL, concentration of macromolecules and the amount of competing 
water molecules for the cross-linking agent). Therefore, cross-linking is expected to be 
higher within the crowded cellular cytoplasm such as the cell inhibition assay (an estimated 
concentration of 300-400 g/l of protein and RNA inside E. coli) (Ellis, 2001). On the other 
hand, cross-linking is expected to be lower in dilute solutions such as the LDH coupled assay 
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(4.4 x10-3 g/l of TvMGL1 and 0.15 g/l of LDH) and the cross-linking experiment (0.88 g/l of 
TvMGL1). 
In the PLP model system, analysis of the results suggests that the processing of DFM and 
TFM by MPAL leads to the production of thioformyl fluoride and thiocarbonyl difluoride, 
respectively. Therefore, it was very likely that these intermediates were generated during the 
course of the enzymatic reaction, since MPAL is known to follow the same γ-elimination 
reaction steps as MGL in the turnover of methionine (Johnston et al., 1981; Karube and 
Matsushima, 1977). Thus, thioformyl fluoride has the potential to thioformylate an amine, 
while thiocarbonyl difluoride has the potential to sequentially thiocarbamoylate two amines. 
The model proposed above did not rule out the possibility that thioformyl fluoride might 
sequentially react with two amines to produce an amidine with the elimination of the sulfur 
atom as hydrogen sulfide (Figure 3.10c). Evidence for the latter proposal is supported by the 
intermolecular cross-linking of TvMGL1 for the enzymatic processing of DFM (Figure 
3.11). The results suggest that upon processing of DFM by TvMGL1, the enzyme (~44 kDa) 
is cross-linked to an adjacent subunit to form a covalently linked dimer (~88 kDa), which is 
similar to the cross-linking pattern observed for the two positive controls (formaldehyde and 
TFM). The enzymatic processing of DFM leads to two faint, higher molecular proteins on 
the gel that correspond to cross-linked trimers (~132 kDa) and tetramers (~176 kDa), which 
is consistent with the cross-linking pattern for the positive control (formaldehyde). The 
intermolecular cross-linking results were unexpected since the release of thioformyl fluoride 
was expected to react with only a single lysine. Overall, the additional finding remained 
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consistent with the idea that basic side chain residues on the surface of the enzyme are 
susceptible to covalent modification following the processing of the fluorinated methionine 
analogs by MGL. The different modes of covalent modification described in this paper 
suggest that there are likely a variety of cytotoxic and/or inhibitory events taking place 
within the organism expressing MGL.  
In the E. coli model system, the quantity of the fluorinated methionine analog required to 
inhibit 50% of cell growth was two-fold greater than the values obtained for the intact 
parasites, T. vaginalis in a 24 hr time period (reported here; Table 3.5) and E. histolytica 72 
hr time period (Tokoro et al., 2003). This might indicate that there were some limitations to 
using the E. coli model when compared to intact parasite studies, such as the differences in 
their metabolism (see below). Overall, the model system provides a facile and safer screening 
method for testing potential compounds before further evaluating the compound on MGL-
containing organisms, such as T. vaginalis, E. histolytica and Porphyromonas gingivalis. 
For the processing of the fluorinated methionine analogs by MGL, the reaction of the 
thioacylating agent with cellular macromolecules was likely the mode of cellular toxicity, 
given the evidence supporting its existence in this study. In the E. coli model, it was unlikely 
that cellular toxicity arisen from the release of the fluoride ion upon hydrolysis from the 
thioacylating agent; since a high concentration of NaF was required to inhibit E. coli growth 
(Table 3.5), which was consistent with a previous study (von Hofsten, 1961a). In a similar 
study, cell growth is not inhibited when intracellular fluoride is released upon induction of β-
galactosidase by fluoro β-D-galactoside (which is known to hydrolyze intracellularly to 
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fluoride ion) does not inhibit cell growth in E. coli (von Hofsten, 1961b). In T. vaginalis, the 
release of toxic H2S upon hydrolysis of thiocarbonyl difluoride as reported by Careless et al. 
(1973) is not likely to inhibit cell growth; since the anaerobic parasitic protozoa lacks the 
cellular target, cytochrome oxidase (Muller, 1988); and MGL is implicated in generating H2S 
from homocysteine for cysteine biosynthesis (Sato et al., 2008; Westrop et al., 2006). On the 
other hand, H2S may inhibit the growth in E. coli since the organism contains cytochrome 
oxidase (Savage, 1977). 
In summary, a detailed investigation of the enzymatic processing of fluorinated 
methionines was undertaken, providing insight into the mechanistic aspects of substrate and 
inhibitor turnover by this key protozoan enzyme. Trapping of the resulting reactive 
compounds (the thioacylating agents) provides, for the first time, chemical knowledge of the 
structure and reactivity of these compounds. The toxicity of these compounds were further 
studied in intact E. coli and T. vaginalis, and provide further impetus to the exploration of 
these fluorinated structural types to other areas of cellular biochemistry. 
 
3.7. Materials and Methods 
3.7.1. Materials 
Biological reagents and chemicals were purchased from Bioshop and Sigma Chemicals 
respectively, unless otherwise stated. The cell line, M15pREP4 E. coli that contains the gene 
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encoding mgl1 from Trichomonas vaginalis was a gift from Dr. G. Coombs (University 
Strathclyde, Glasgow, UK). 
 
3.7.2. Protein Purification 
The recombinant enzyme, TvMGL1 was purified from M15pREP4 E. coli as described by 
McKie et al. (1998) with some minor changes. Following the purification of the enzyme 
from the Ni2+-NTA superflow resin (Qiagen), the enzyme (1 mL) was dialyzed (4 x 1 L) 
against buffer (100 mM sodium phosphate buffer at pH 7.8, 10 mM EDTA, 0.2 M NaCl, 4 
mM DTT and 100 μM PLP), over a period of 15 hr at 4°C. The samples were concentrated to 
25 mg mL-1 with a 10k MWCO centrifuge tube (Sartorius Stedim Biotech & Corning), flash 
frozen in liquid nitrogen and stored at -80°C for future use (stable for more than a month). 
Total amount of enzyme obtained from 1 L culture was 15 mg. 
ESI-MS calculated for TvMGL1 was 43 960.47, observed 43 957.5 ± 4.4.  
 
3.7.3. MBTH Assay Method for Detecting α-Ketobutyrate 
The activity of MGL was initially monitored by utilizing the MBTH assay as previously 
reported (Soda, 1968) . The reaction mixture (50 μL) consisted of 60 mM HEPES-NaOH, pH 
8.0, 20 μM PLP, 2 mM DTT, 0.1 to 4.0 mM substrate, and 0.5 μM TvMGL1. All other 




3.7.4. Michaelis-Menten Kinetics 
In the LDH coupled assay, the reaction mixture (300 μL) consisted of 60 mM HEPES-
NaOH, pH 8.0, 5.0 Units LDH porcine heart (Calbiochem; Cat# 427211), 400 μM NADH 
(Sigma-Aldrich; extinction coefficient of 6.22 mM-1 cm-1) (Dawson, 1985), 0.1 μM 
TvMGL1, 10 μM PLP, and 0.1-1.2 mM substrate. The reaction was incubated for 2 min at 
37°C on a 96 well plate (Greiner Bio One) and initiated with the addition of TvMGL1. The 
data was collected with a Spectramax M5 plate reader (Molecular Devices Corporation, 
Sunnyvale, CA), and the kinetic values were determined with Microcal™ Origin® v6.0 
(Microcal Software, Northampton, MA) using the Michaelis-Menten equation. In the 
presence of pyruvate, 1 Unit of LDH will oxidize 1 μmole NADH per min at 25°C, pH 7.4, 
as reported by the manufacturer (Calbiochem). In the presence of α-ketobutyrate, 0.1 Unit of 
LDH will oxidize >0.02 μmole NADH per min at 37°C, pH 8.0. 
 
3.7.5. 19F-NMR Experiments 
The processing of TFM and DFM were detected by 19F-NMR and 1H-decoupled 19F NMR, 
respectively using a 600 MHz NMR (Bruker) spectrometer. The reaction mixture consisted 
of 20 μM PLP, 30 mM HEPES-NaOH, pH 7.2, 4.2 mM substrate and 10% (v/v) D2O. The 
reactions were performed at 25°C and initiated with the addition of 0.50 μM TvMGL1. The 
19F-NMR data (externally locked with CFCl3) δ: -93.3 ppm for DFM, -41.4 ppm for TFM 




3.7.6. Theoretical Calculation of the 19F-NMR Chemical Shifts 
The 19F NMR shielding constants were calculated at the Hartree-Fock level (HF/6-
311+G(d,p)//B3LYP/6-31G(d)) gauge-invariant atomic orbitals (GIAO), Møeller-Plesset 
theory (MP2/6-311++G(2d,p)//B3LYP/6-311++G(2d,p)) GIAO, and the density functional 
theory (DFT/B3LYP/6-31+G(df,p)//B3LYP/6-31+G(df,p)) GIAO levels (Ditchfield, 1974). 
An IR frequency check was performed in order to ensure the lowest ground state structures 
were utilized, and the theoretical chemical shifts were referenced to CFCl3. Spartan ’08 and 
Gaussian ’03 were utilized for these calculations (Frisch et al., 2003b; Shao et al., 2006)  
 
3.7.7. Theoretical Calculations of the Heats of Formation 
The G3(MP2) theory, based on MP2(full)/6-31G(d) geometries using all electrons, has an 
overall average absolute deviation of 1.02 kcal/mol for a set of 299 organic molecules 
(Curtiss et al., 1999). The reference energy is calculated with accurate quadratic 
configuration interaction (QCISD(T)/6-31G(d)), and is then modified by a series of 
corrections to obtain a total energy, E0 
E0[G3(MP2)] = QCISD(T)/6-31(d) + ΔEMP2 + ΔE(SO) + E(HLC) + E(ZPE)   (1) 
Where ΔEMP2 = [E(MP2/G3MP2large)]-[E(MP2/6-31G(d)]     (2) 
The energy corrections in Eq. (1) consist of an equilibrium geometry correction (ΔEMP2), 
spin-orbit corrections (ΔE(SO)) for atomic species only, zero-point corrections (E(ZPE)) are 
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obtained from scaling harmonic frequencies by 0.8929, “higher level correction” (HLC) for 
open shell molecules and for atoms (Curtiss et al., 1998; Curtiss et al., 1999). 
The T1 recipe is similar to the G3(MP2) recipe, except that the geometry optimization with 
MP2/6-31G* basis set is replaced by the use of a HF/6-31G* basis set, the MP2/G3MP2large 
energy is approximated with the dual basis set RI-MP2 techniques, and QCISD(T) 
calculations and zero-point corrections are removed from the recipe (Ohlinger et al., 2009). 
The T1 procedure reduces the computation time by 2-3 orders of magnitude when compared 
to the G3(MP2) recipe. The heats of formation are reported to reproduce the values with a 
mean absolute error of 8.5 kJ/mol for a set of 1805 diverse organic molecules (Ohlinger et 
al., 2009). 
 
3.7.8. Theoretical Calculation of the pKa Values for the Thiol Compounds 
The pKa values for the thiols were calculated using the Jaguar v4.1 pKa module (Schrödinger 
Inc), which involved geometry optimization for the protonated and deprotonated species at 
the HF/B3LYP/6-31G* level of theory, accurate single point energies for the species at the 
DFT/cc-pVTZ(+) level of theory, and the computation of the solvation free energy of the gas 
phase geometry optimized species. The theoretical pKa values for the reference compounds 
CH3SH (10.6), CH3CH2SH (10.6) were similar to the reported literature values (10.3 and 
10.6 respectively); and HOCH2CH2SH (10.2) and HSCH2CH2SH (10.2) where ~1 pKa 




3.7.9. Cross-linking of MGL Protein Upon Processing of Fluorinated Analogs 
For the MGL intermolecular cross-linking experiments, the reaction mixture (50 μL) 
consisted of 100 mM HEPES-NaOH, pH 8.0, 5.0 mM EDTA-NaOH at pH 8.0, 4.2 mM of 
the fluorinated methionine analog (or 4.2 mM methionine in the presence or absence of 40 
mM formaldehyde), and 20 μM TvMGL1. The reactions were quenched by the addition of 2-
fold loading buffer [100 mM Tris, pH 6.8, 2% (v/v) β-mercaptoethanol, 4% (v/v) SDS, 0.2% 
(w/v) bromophenol blue, 20% (v/v) glycerol], and 10 μL aliquots from the reaction mixture 
were resolved on a 13% (w/v) SDS-polyacrylamide gel at 200 volts. For the inhibition of 
cross-linking of MGL, a final concentration of 50 mM cysteamine at pH 8.0 was added to the 
reaction mixture. The integrated density value for the stained protein bands were calculated 
with AlphaEase®FC software v6.0 (Alpha Innotech Corporation; San Leandro, CA, USA). 
 
3.7.10. Model Processing of Fluorinated Analogs 
For the PLP model system, 1.0 mM of the fluorinated methionine analog and 0.10 mM 
MPAL were incubated in a 2.0 mM KOH/methanol solution for 1 hr at 21°C. Afterwards, a 
final concentration of 0.10 mM Al(NO3)3 and 900 mM morpholine were added sequentially 
to the reaction mixture, and incubated for 15 hr at 21°C. The product of the TFM reaction 
was extracted with ethyl acetate and dried under vacuum, while the DFM reaction was 
extracted with CHCl3. The extracted products for the DFM and TFM were developed by 
TLC with CH2Cl2 and ethyl acetate/ethanol (4:1 ratio), respectively, visualized at 320 nm and 
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with iodine stain, and compared to the authentic standards. The yields for 4,4’-
thiocarbonyldimorpholine and fluoride based on NMR spectroscopy were 50% and 82%, 
respectively for the processing of TFM (Table 3.3). The yields for 4-thioformylmorpholine 
and fluoride, based on NMR spectroscopy, were 16% and 83%, respectively for the 
processing of DFM (Table 3.3). 
 
3.7.11. Syntheses 
The synthesis of the fluorinated methionine analogs was adapted from previously reported 
procedures (Houston and Honek, 1989; Tsushima et al., 1990). In a 3-neck round bottom 
flask fitted with a dry ice/acetone condenser, L-homocystine (3.8 mmol, 1.0 g) was stirred in 
liquid ammonia (50 mL) at -75°C, and the disulfide bonds were reduced with a slight excess 
of sodium metal (until a purple color remained for 20 min). The reaction was carefully 
quenched by the addition of ammonium chloride until the sodium metal was completely 
reduced, and liquid ammonia was evaporated off. Potassium t-butoxide solution (17.8 mmol, 
2.00 g) in deoxygenated ethanol (15 mL) was added dropwise to the mixture over a period of 
30 min. Chlorodifluoromethane or iodotrifluoromethane (under UV-light) was bubbled into 
the solution for 2 hr to yield DFM or TFM, respectively. The reaction was allowed to stand at 
21°C for 15 hr, and quenched with concentrated HCl to a pH of 7. The white solid was 
suspended in methanol (30 mL) and the inorganic salts were removed by filtration. The 
fluorinated methionine analogs were purified with a RediSep C18 reverse phase column 
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(Teledyne Isco, Lincoln, NE; water/acetonitrile, 10:1). The spectroscopic properties were in 
complete agreement with those previously published (Houston and Honek, 1989). 
The synthesis of 4,4’-thiocarbonyldimorpholine was performed as described by Beerheide 
et al. (2000). Briefly, morpholine (1.0 mmol, 90 μL) and triethylamine (0.50 mmol, 70 μL) 
were added to a solution of 1,1’-thiocarbonyldiimidazole (0.50 mmol, 89 mg) in CH2Cl2 (1 
mL) at 4°C with stirring. The reaction was warmed up to 21°C, which turned pale orange 
after 3 hr, and quenched with brine (4 mL) after 4 hr. The organic layer was combined, dried 
over magnesium sulphate, filtered, and purified by silica gel chromatography. 
4,4’-Thiocarbonyldimorpholine was obtained as an oil (54 mg, 50%). Rf (ethyl 
acetate/hexane, 1:1) 0.39. 1H-NMR (CDCl3) δ: 3.59 (t, J = 4.9 Hz, 8H), 3.72 (t, J = 4.9 Hz, 
8H). MS-ESI calculated for C9H17N2O2S
+ [M+H]+ 217.10121 found 217.0899. 
The synthesis of 4-thioformylmorpholine was performed as described by Mills (1986). 
Briefly, a mixture of N,N’-dimethyl thioformamide (1.50 mmol, 150 mg) and morpholine 
(1.50 mmol, 130 μL) in toluene (5 mL) was contained in a three-neck, 25 mL round bottom 
flask with an Ar inlet tube, water-cooled condenser, magnetic stirring bar, and refluxed at 
115°C for 15 hr. The sample was concentrated in vacuo and purified by silica gel 
chromatography. 
4-Thioformylmorpholine was obtained as a light brown solid (118 mg, 60%): mp 67-67.5°C 
(lit. 67-68°C) (Mills, 1986). Rf (ethyl acetate/CH2Cl2, 1:4) 0.34. 
1H-NMR (C6D6) δ: 2.33 (t, J 
= 4.9 Hz, 2H), 2.80 (t, J = 4.9 Hz, 2H), 3.03 (t, J = 4.9 Hz, 2H), 3.61 (t, J = 4.9 Hz, 2H), 8.76 
(s, 1H). MS-ESI calculated for C5H10NOS
+ [M+H]+ 132.04840 found 132.0432. 
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The synthesis of MPAL was adapted from procedure previously reported (Heyl et al., 
1951; Johnston et al., 1981). Briefly, pyridoxal hydrochloride (4.9 mmol, 1.0 g) was 
dissolved in anhydrous methanol (6.25 mL), which was contained in a three-neck, 500 mL 
round bottom flask with a water-cooled condenser, magnetic stirring bar, and refluxed at 
60°C for 15 min. The solution was cooled and sodium bicarbonate (5.0 mmol, 0.42 g) was 
added to the mixture, and refluxed for an additional 1.5 hr. The sodium chloride precipitate 
from the cooled solution was filtered and washed with anhydrous methanol (4 mL). Benzene 
(200 mL) and methyl iodide (240 mmol, 15.0 mL, very toxic) were added sequentially to the 
methanol solution, which was contained in a three-neck, 500 mL round bottom flask with a 
water-cooled condenser, magnetic stirring bar, and refluxed in the dark at 60°C for 15 hr. 
The solution was distilled to dryness as a yellow residue in a water bath in vacuo, and 
crystallized from methanol-ether to afford pyridoxal monomethylacetal iodide (950 mg, 
60%). Pyridoxal monomethylacetal iodide (1.4 mmol, 0.45 g) was dissolved in water (7 mL), 
and silver chloride (1.70 mmol, 250 mg) was added with stirring for 2 hr in the dark at 21°C. 
The mixture was filtered, titrated to pH 2.0 with 1N HCl, evaporated to dryness in vacuo, and 
crystallized from water-acetone. 
N-Methyl pyridoxal chloride was obtained as white crystals (107 mg, 35%): decomp. 120°C 
(lit. 120°C) (Heyl et al., 1951). 1H-NMR (D2O) δ: 2.60 (s, 3H), 4.16 (s, 3H), 5.19 (dd, J = 
47.0, 13.8 Hz, 2H), 6.66 (s, 1H), 8.13 (s, 1H). MS-ESI calculated for C9H12NO3
+ [M]+ 




3.7.12.  Cloning of mgl1 into the pET28b Vector and Cell Inhibition Assay 
The mgl1 gene from the pMGL4100 plasmid was cloned into the pET28b vector (Novagen, 
Madison, WI) at the NcoI and XhoI sites with the appropriate restriction enzymes (NEB). 
The gene was amplified by overlap extension PCR with Pwo SuperYield DNA polymerase 
(Roche Applied Science, Indianapolis, IN), which replaced an internal XhoI site with a non-
degenerate codon, and introduced a linker sequence at the C-terminus of the sequence. The 
primer pair (Invitrogen, Burlington, ON) termed “MGL1 forNcoI” (5’-GATATACCATGG-
CGCACGAGAGAATGAC-3’) and “MGL1 revC222G” (5’-TTCTGTTTTCTCCAg-
GAAGGCGATCTTGC-3’) generated the N-terminal fragment, which introduced the NcoI 
restriction site (underlined) and non-degenerate codon (lower case letter), respectively. The 
primer pair termed “MGL1 forC222G” (5’-ATCGCCTTCCTgGAGAAAACAGAAAGC-
ATG-3’) and “MGL1 rev1aTHB” (5’-cacgtggcaccagacctAAAA-GAGCGTCAAG-3’) 
generated the C-terminal fragment, which introduced the non-degenerate codon (lowercase 
letters) and linker region (lower case lettering and underlined), respectively. The N-terminal 
fragment and C-terminal fragment were combined and amplified with the primer pair termed 
“MGL1 forNcoI” and “MGL1 rev1bXhoI” (5’-GTAAATCTCGAGgctaccacgtggcaccagac-
3’), which introduced the XhoI site (uppercase lettering and underlined) and the linker region 
(lowercase letters and underlined); and thereby, generating the ORF of mgl1. Amplification 
of the PCR products was carried out under the following conditions: denatured at 95°C, 1’; 
18 cycles (95°C, 1’; 63°C, 1’; 72°C, 1’45”); and 11 cycles (95°C, 1’; 63°C, 1’; 72°C, 1’ 35”) 
and 72°C, 5’. The PCR products were recovered using a Silica Bead DNA Gel Extraction Kit 
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(Fermentas, Hanover, MD). The PCR products and the pET28b vector were doubled digested 
with NcoI and XhoI restriction enzymes (NEB, Ipswich, MA), purified using the Silica Bead 
DNA Gel Extraction kit, and ligated with T4 DNA ligase (NEB). The ligation mixture was 
transformed into electrocompetent XL-1 Blue cells (Stratagene, La Jolla, CA) and selected 
on Luria Bertani (LB)-agar media with 35 mg/L KAN. The plasmids with the insert were 
purified from the transformed cells using a QIAGEN miniprep kit (QIAGEN, Valencia, CA), 
and then transformed into electrocompetent BL21 (DE3) cells (Stratagene). The gene 
sequence for the MGL1 construct was verified by DNA sequencing (DNA Sequencing 
Facility, Department of Biology, University Waterloo, Waterloo, ON). 
In the cell growth inhibition assay, the BL21 (DE3) cells (Stratagene) containing the 
recombinant MGL (as described above) were grown overnight at 37°C in the presence of 35 
mg/L KAN, inoculated into 10 mL LB media (2 x106 cells/ml) containing, 35 mg/L KAN 
and induced with 0.1 mM IPTG for 30 min at 37°C with shaking. The cells were diluted two-
fold in a 96 well plate (Falcon), which contained 35 mg/L KAN, 0.1 mM IPTG and the 
compound of interest. The plate was sealed with a gas permeable tape, the cells were grown 
at 37°C, and the readings were taken at 600 nm when the negative control cells (in the 
absence of the compound) reached an optical density of 0.15 to 0.16. The percent growth 
inhibition for each compound was normalized to the uninhibited growth of the negative 
control cells. The EC50 values of the compounds were determined with Microcal™ Origin
® 
v6.0 using the Hill equation. 
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In the growth inhibition of T. vaginalis, the procedures were followed as described by 
McMillan et al (2009). Briefly, the cells were diluted by two-fold in a 96 well plate (to a final 
concentration of 105 cells/ml) in Modified Diamond’s medium with 10% (v/v) heat 
inactivated horse serum and the compound of interest. The plates were sealed with a gas 
permeable tape and incubated for 18 to 22 hrs at 37°C in a humidified box. Aliquots were 
transferred to a black, 96-well luminometer plate and luminescence was measured with Cell 
Titer-Glo® Assay (Promega). The EC50 values were determined with Microcal™ Origin
® 













Where A1 is the lowest value, A2 is the highest value, x is the concentration of compound and 
n is the Hill slope. 
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CHAPTER 4  
SYNTHETIC ROUTES TO 3,3-DIFLUORO-O-METHYL-L-
HOMOSERINE 
 
4.1. Authors’ Contributions 
Dr. G. Coombs provided the mgl1 gene from Trichomonas vaginalis G3. Dr. R. Smith 
obtained the ESI-MS data for the enzyme and reported compounds. C. Myers obtained the 
ESI-MS data for O-methyl-L-homoserine. Q. Bhatti synthesized compound 4.45, and 
performed the fluorination of the model β-ketoester with Xtalfluor E and compound 4.35a 
under the guidance of I. Moya. Q. Bhatti and I. Moya synthesized compounds 4.35a and 




A C(sp3)-F bond has an average energy of approximately 105 to 116 kcal mol-1, which makes 
it one of the strongest covalent bonds available in organic chemistry (Berkowitz et al., 2008). 
In combination with fluorine’s low polarizability, these properties are ideal for protecting 
labile sites within a compound against metabolic processes (O'Hagan, 2008). These 
properties stem from the fact that fluorine is the most electronegative element in the periodic 
table; and therefore, has the greatest propensity to attract electron density (O'Hagan, 2008). 
Thus, introducing a C-F bond alters the physical and chemical properties of an organic 
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compound, which is useful for the development of biologically active compounds (Berkowitz 
et al., 2008). 
Another application of a C-F bond is in nuclear medicine, where radioactive isotope 
fluorine-18 is incorporated into a cell specific marker in order to serve as an imaging agent in 
the diagnosis of diseases (Vallabhajosula, 2007). The naturally stable isotope fluorine-19 has 
been applied to substrate binding and/or changes in enzyme conformation by 19F-NMR as a 
result of the sensitivity of fluorine’s nuclei to small changes in the microenvironment of the 
protein (Danielson and Falke, 1996). The method is also useful in monitoring the activity of 
an enzyme, and to obtain accurate IC50 values for drug candidates (Papeo et al., 2007). In a 
similar 19F-NMR study, fluorinated L-amino acids have been incorporated into enzymes in 
order to correlate the chemical shifts of the fluorine nuclei to the conformational changes of 
the enzyme alone and upon binding of the ligand, such as the reported studies of 
trifluoromethionine and difluoromethionine incorporation into lambda lysozyme, and 5-
fluoroleucine incorporation into dihydrofolate reductase (Duewel et al., 1997; Duewel et al., 
2001; Feeney et al., 1996; Vaughan et al., 1999). Thus, 19F-NMR is a sensitive tool to 
monitor the chemical shifts of the fluorine nuclei upon perturbation of the protein’s 




4.3. Chemical Properties of the Fluorine Atom 
Even though fluorine has a similar size as a hydroxyl group (a van der Waals radii of 1.47 Å 
and 1.57 Å, respectively), the two atoms nevertheless possess important differences 
(O'Hagan and Rzepa, 1997). In comparison to the hydroxyl group, the electrostatic influence 
of fluorine is weaker because of its very high polarizability volume (units of Å3 atom-1) and 
electronegativity (Nagle, 1990). Based on high level theoretical calculations at the MP2 level 
of theory, there is a reduction in strength for hydrogen bonding of the fluorine atom to water 
(O'Hagan and Rzepa, 1997). For example, the F···H hydrogen bond between fluoromethane 
(CH3F) and a water molecule has a calculated strength of 2.38 kcal mol
-1 (a distance of 1.9 
Å); while an O···HO hydrogen bond for a methanol-water interaction has a strength of 4.48 
kcal mol-1 (a distance of 1.942 Å), and an O···HO hydrogen bond for a water-methanol 
interaction has a strength of 5.15 kcal mol-1 (a distance of 1.90 Å; Figure 4.1) (Fileti et al., 
2004; Howard et al., 1996). Thus, fluorine acts as a poor hydrogen bond acceptor when 
compared to the hydroxyl group; and in most cases, such a substitution reduces the binding 
affinity and/or turnover of the analog by the target enzyme (Howard et al., 1996). 
 
 
Figure 4.1. Hydrogen bonding interactions between water and C(sp3)-X groups. 
The figure was adapted from Howard et al. (1996) and Fileti et al. (2004). 
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4.4. Conformational Preference of Fluorinated Molecules 
Before examining the effects of C-F bond on the conformational preference of a molecule, 
various models to explain these preferences will be presented. The Pauli repulsion model will 
be discussed in greater detail because of its ability to explain the conformational preference 
adopted by fluorinated molecules. However, by no means does this quantum mechanical 
model give a complete and accurate picture. 
 
4.4.1. Models for the Preferred Conformation of Molecules 
The anomeric effect is a classical example of an electronegative atom influencing the 
stereochemistry of a molecule (O'Hagan, 2008). For example, an electronegative substituent 
that is attached to the C1 atom of a pyranoid ring has a tendency to adopt the axial rather than 
equatorial orientation (Figure 4.2a). Visualizing the effect with a Newman projection from 
the C1-O bond on-end, the antiperiplanar position for the fluorine atom (torsion angle ±150° 
to 180°) is favoured over the gauche position (torsion angle ±60°) as a result of steric 
repulsion and a reduction in dipole-dipole repulsion (Figure 4.2a) (Mo, 2010; Trapp et al., 
2006; Vila et al., 2011). An alternative model to describe the antiperiplanar position for 
electronegative atom in the axial preference is hyperconjugation, which involves electron 
delocalization of lone pair electrons to an anti-parallel, empty antibonding orbital (termed 
nσ* interaction; Figure 4.2b) (O'Hagan and Rzepa, 1997). However, the model cannot 
explain why this process is reversed, i.e., a shift from an axial to an equatorial conformation 
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in the pyranoid ring, when a less electronegative atom at the C1 position such as nitrogen or 
a more polar solvent such as water is used (Juaristi et al., 1986; Lemieux et al., 1969). 
 
 
Figure 4.2. Stereochemistry of a carbohydrate and stabilizing hyper-conjugation 
effects. 
a) The stereochemistry of a fluorine atom in the antiperiplanar conformation (left) and 
the gauche conformation (right). b) The antiperiplanar conformation which is suitable 
for nσ* interaction (neutral hyperconjugation). The figure was adapted from 
O’Hagan and Rzepa (1997). 
 
The contribution of hyperconjugation, on the conformational preference of carbohydrates, 
is reported to be negligible when examined by the block localized wavefunction method, 
which calculates the extent of electron delocalization for an O-C-X bond that contains an 
electronegative substituent at position X (Mo, 2010). The model suggests that steric effects 
caused by Pauli repulsion and electrostatic interactions will contribute to the stereochemical 
preference of fluorinated carbohydrates (and possibly fluorinated molecules in general) (Mo, 
2010; Ren, 2006). These results are consistent with several lines of studies, such as 
perturbation theory, minimization of dipole-dipole interactions at the axial position in the 
gas-phase and non-polar solvents, and stabilization of dipole-dipole interactions at the 




density within the carbohydrate (Bingham, 1976; Gillespie, 1967; Mo, 2010; Vila et al., 
2011). 
As a side note, the Pauli repulsion model describes the nature of two electrons of different 
coordinates (spin and spatial) to exist in the same orbital provided that their wavefunctions 
are antisymmetric. On the other hand, electrons of the same coordinate (spin and spatial) will 
not exist because the wavefunction is non-existent (i.e. the electrons are mutually repulsive). 
The rule establishes where an electron pair will be arranged in a molecule, and the probable 
molecular shape of the molecule (Gillespie, 1967). Therefore, the electron pair in a given 
molecular orbital maximizes its distance or delocalize its electrons away from the 
neighbouring orbital in order to reduce the electrostatic repulsion (as defined by F = 1/r2) 
(Gillespie, 1967). 
The effects of electrostatic repulsion are observed in the bond angles of monofluoro-
methane (relative to methane), the F-C-H bond angles decrease and adjacent H-C-H bond 
angles increase, as a result of an increase in s character for the hybridization orbital of the F-
C bond and a corresponding decrease in s character (a corresponding increase in p character) 
for the hybridization orbital of the C-H bond (Figure 4.3a) (Gillespie, 1967; Wiberg and 
Murcko, 1988). In other words, the hybridization orbital of the F-C bond is smaller in size 
than the C-H bonds. This is reflected by alterations in the ideal VSEPR bond angles of 
adjacent atoms due to changes in electrostatic repulsion between the different sizes of 
hybridization orbitals.  
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Consequences of an increased bond angle in a molecule may lead to an increase in entropy 
(O'Hagan and Rzepa, 1997), as reported for lipids that contain a CF2 substitution 
(McDonough et al., 1983). Normally, the carbon chain of the lipid will adopt a trans 
conformer, but a CF2 substitution reduces the energy of the gauche conformer and is 
reflected by an increase in distance between the two 1,4 hydrogen atoms due to a wider bond 
angle (Figure 4.3b)(O'Hagan and Rzepa, 1997; Sturtevant et al., 1979). Additionally crystal-
lographic and theoretical evidence supports a widening of C-CX2-C angle from a sp
3 
tetrahedral angle (109.5°) in hydrocarbons to 115-119° in CF2 methylene systems (Chambers 






Figure 4.3. The relationship between bond angles of a molecule and percent 
bonding character of substituted electronegative atoms. 
a) An increase in percentage of s character (i.e., decrease in p character) for the C-X 
bond coincides with a decrease in bond angle for the electronegative atom (A-C-X). 
b) An increase in bond angles from X-CH2-X (left) to X-CF2-X (right) for butane 
leads to an increase in the bond distance of 1,4-hydrogen interactions in the gauche 
conformer. Geometry optimization and wave functions of the molecules were 





obtained with HFT/6-31G*//HFT/6-31++G** basis sets, and the figure was adapted 
from O`Hagan (2007) and Wiberg and Murcko (1988). 
The extent of electrostatic interactions for the gauche preference of 1,2-difluoropropane 
and 1-fluoropropane has yet to be determined; however, MP2 level calculations suggest that 
hyperconjugation may be the dominant effect (Bitencourt et al., 2007; Goodman and Sauers, 
2005). Perturbation theory is an alternative explanation for the preferred gauche conformer of 
fluorinated alkanes, which explains the optimal conformer in terms of maximizing 
overlapping orbitals while minimizing Pauli repulsion energies (Bingham, 1976). The theory 
states that delocalized electrons of non-bonding (or bonding) orbitals will adopt a trans 
conformer when the antibonding orbital of the neighbouring atom is empty. The trans 
conformer reduces the extent of electron repulsion within a molecule by minimizing the 
energy gap for electron delocalization to occur (e.g., the s-trans conformer of 1,3-butadiene 
are favoured over the s-cis conformer) (Squillacote et al., 1979). On the other hand, 
delocalized electrons are unfavourable when occupied non-bonding (or bonding) orbital 
encounters an occupied antibonding orbital. The molecule will adopt a gauche conformer in 
order to reduce the electrostatic repulsion associated with filled orbitals, which is dependent 
on the electronegativity of the donor atom (Bingham, 1976). Thus, a gauche conformer is 
favoured when the donor atom is more electronegative, which increases the energy gap 
between the two filled molecular orbitals (e.g., fluorinated carbon; Figure 4.4) (Bitencourt et 
al., 2007; Durig et al., 2005). Overall, the perturbation theory is a useful model in explaining 





Figure 4.4. Energy difference between trans and gauche conformers. 
The energy difference between trans and gauche conformers for a) 1,2-difluoroethane, 
b) 1-fluoropropane, c) 1,1-difluoropropane (methyl group relative to the lone 
hydrogen atom) and d) 1,2-difluoropropane. The energy minimum for each rotamer 
was optimized at the MP2 level of theory with either 6-31+G* (for 1,2-difluoroethane 
and 1-fluoropropane), augmented correlation-consistent polarized valence-only triple-
zeta (aug-cc-pVTZ level; for 1,2-difluoropropane), or 6-31G(d) (for 2,2-
difluoropropane). The figure was adapted from Rablen et al. (1999), Durig et al. 
(2005) and Bitencourt et al. (2007). 
 
4.5. Fluorination Reagents and Applications 
Deoxyfluorination using nucleophilic-type fluorinating reagents was first employed with SF4 
(4.1) in the transformation of hydroxyl groups to fluorides, carbonyl groups to 
difluoromethylene, and carboxylic acid groups to trifluoromethylene functionalities (Figure 
4.5 a and d) (Hasek et al., 1960). The fluorination reagent 4.1 is a gaseous substance, 
extremely toxic and corrosive. It also requires extensive safety measures, high temperatures 
(100°C) and specialized equipment. On the other hand, the organic fluorinating reagent, 
diethylaminosulfur trifluoride (DAST, 4.2) became widely popular in fluorine chemistry 
(Figure 4.5) because of its wide spectrum of applicability, exists as a liquid, utilizes lower 
 
104 
temperatures, and produces fewer side products (Middleton, 1975b). The only concern when 
handling DAST is its potential to explode upon heating above 90°C. This led to further 
improvements in its heat stability with the modified fluorinating reagent, 
diethylaminodifluoro-sulfinium tetrafluoroborate (XtalFluor-E; 4.3; Figure 4.5) in 
conjunction with an HF amine salt such as Et3N*3HF, while maintaining the same 
deoxyfluorination selectivity as DAST (L’Heureux et al., 2010). 
 
 
Figure 4.5. Fluorination reagents and deoxyfluorination of molecules. 
a) Fluorination reagents: sulfur tetrafluoride (4.1), diethylaminosulfur trifluoride 
(4.2), and diethylamino-difluorosulfinium tetrafluoroborate (4.3). Deoxyfluorination 
of d) carbonyl and hydroxyl groups to their corresponding fluorocarbons. The figure 
was adapted from L’Heureux et al. (2010).  
 
In the literature, there is a lack of evidence to suggest that DAST will fluorinate β-keto 
esters (4.4) to produce 3,3-difluoroesters (4.5). There is only one successful report by Buss et 
al. (1986) where 3,3-difluoroesters (4.5) are generated with DAST in a non-polar, non-basic 
solvent with a 76% yield (Figure 4.6a). All other reports with β-ketoester starting materials 
4.1 4.2 4.3 
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afford α-fluoro-β-ketoesters 4.6 and vicinal difluoro-olefin side products 4.7 when treated 
with one and two equivalents of DAST, respectively (Figure 4.6b) (Asato and Liu 1986, 
Bildstein et al. 1995, and Singh 2002). In the fluorination of carbonyl groups, DAST has the 
potential to favour carbonium ion-type rearrangements in non-basic polar (e.g., methylene 
chloride) and basic polar solvents (e.g., tetrahydrofuran) (Middleton, 1975a). A classic 
example of such a case is the fluorination of the acid sensitive pivaldehyde (4.8) in a non-
polar non-basic solvent (e.g., pentane), which affords 1,1-difluoro-2,2-dimethyl-propane 
(4.9). However, fluorination in a non-basic polar solvent affords 2-methyl-2,3-difluorobutane 
(4.10), and fluorination in basic polar solvents affords 3-fluoro-2-methyl-but-1-ene (4.11) as 
a result of rearrangement of the carbocation (Figure 4.6c) (Middleton, 1975a). 
The complication of fluorinating β-ketoesters with DAST likely arises from its inherent 
chemical properties. For example, electrostatic repulsion between carbonyl groups is reduced 
in polar solvents when the β-dicarbonyl exists as the keto form, and consequently enhances 
its solvation energy (Emsley and Freeman, 1987; Rogers and Burdett, 1965a). On the other 
hand, in non-polar solvents, the polarity of β-dicarbonyls is reduced in the enol form than the 
keto form (Emsley and Freeman, 1987; Rogers and Burdett, 1965a). Higher temperatures 
may be employed in order to reduce the extent of the enol form in β-dicarbonyls, because of 
the disruption in intramolecular H-bonding of the cis-enol (Rogers and Burdett, 1965b). 
Thus, changes in concentration, solvent and temperature may alter the equilibrium of the 






Figure 4.6. Fluorination of β-ketoesters and carbonium ion type rearrangement 
of pivaldehyde during deoxyfluorination. 
Fluorination of pivaldehyde (4.8) with DAST may lead to either 1,1-difluoro-2,2-
dimethyl-propane (4.9; nonpolar solvent), methyl-2,3-difluorobutane (4.10; polar, 
nonbasic solvent), or 3-fluoro-2-methyl-but-1-ene (4.11; polar basic solvent). Where 






4.9 4.10 4.11 
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4.6. Mechanism Based Inhibitors 
Mechanism-based inhibitors of enzymes, also referred to as suicide inhibitors, are 
compounds that require binding to the enzyme, and conversion to a reactive species as a 
result of the catalytic capabilities of the active site (Abeles and Maycock, 1976). For 
example, propargylglycine (L-2-amino-4-pentynoic acid, 4.12) acts as a general mechanistic 
inhibitor of PLP-dependent enzymes (Figure 4.7a) (Abeles and Walsh, 1973). The steps 
leading to inhibition involve formation of an aldimine linkage between 4.12 and the enzyme-
bound PLP, followed by labilization of the α-hydrogen atom to afford an imino-γ-alkyne, a 
shift of electrons to afford β,γ-diene 4.14, and the active site base forming a covalent linkage 
to the Cγ atom of the diene via a Michael addition (4.15) (Abeles and Walsh, 1973; 
Silverman and Abeles, 1976). 
For β-eliminating PLP-dependent enzymes, suicide inhibition is not observed for an α-
alkene compounds, since it is hypothesized that the Cβ atom is not sufficiently 
electronegative for nucleophilic attack (Silverman and Abeles, 1976). To improve its 
electrophilicity, halogens are introduced at the Cβ atom to yield compounds such as 3,3-
dichloroalanine (4.18) and 3,3,3-trifluoroalanine (4.19) (Silverman and Abeles, 1976). These 
halogenated compounds are found to inactivate several PLP-dependent enzymes, as a result 




Figure 4.7. Suicide inhibition mechanism of β- and γ-eliminating PLP-dependent enzymes. 
a) Inactivation by propargylglycine (L-2-amino-4-pentynoic acid, 4.12): formation of an aldimine linkage between 4.12 and 
PLP (4.13), formation of an imino-β,γ-diene intermediate (4.14), and inactivation of the PLP-dependent enzyme at the γ-carbon 
atom (4.15). b) Inactivation by β-unsaturated L-amino acids (4.16): formation of an aldimine linkage between 4.16 and PLP, 
formation of a β-unsaturated imine intermediate (4.17), and inactivation of the PLP-dependent enzyme. c) Suicide inhibition of 
a β-eliminating enzyme with either L-dichloroalanine (where X = Cl and R2 = H; 4.18) or L-trifluoroalanine (where X = F and 
R2 = F; 4.19). Formation of an aldimine linkage between the suicide inhibitor and PLP, formation of a imino-acrylate (4.20), 
and inactivation of the PLP-dependent enzyme at the β-carbon atom (4.21) Where R1 = OPO3
2-; the figure was adapted from 
Silvermann and Abeles (1976). 
4.18: X = Cl, R2 = H 
4.19: X = R2 = F 




The goal of this study was to investigate the role of the catalytic residues of MGL with a 
fluorine probe, 3,3-difluoro-O-methyl-L-homoserine (4.23), an oxo derivative of L-
methionine analog (4.24; Figure 4.9). Keqiang et al.(1998) reported the synthesis of 3,3-
difluoro-L-methionine; however, the synthetic route was laborious (19 steps) and an overall 
yield of 0.4% (Figure 4.8). We were unable to obtain the sulfur compound from Dr. Liu for 
our study since it was disposed of upon his move to the University of Texas (personal 




Figure 4.8. The synthetic route of 3,3-difluoro-L-methionine (4.25) from the 
precursor L-ascorbic acid. 
a) Acetone, CuSO4; b) K2CO3, H2O2; c) KI, MeCN; d) LiAlH4, THF; e) NaH, BnBr; 
f) (COCl)2, DMSO, Et3N; g) Diethylaminosulfur trifluoride (DAST), CH2Cl2, -78°C; 
h) Dowex 50 (H+), MeOH; i) t-butyldiphenylsilyl chloride (TBDPSCl), imidazole; j) 
Tf2O, pyridine; k) NaN3, DMF; l) t-Bu4NF, THF; m) CrO3, H2SO4; n) Cl3CC(NH)O-
t-Bu, BF3 Et2O; o) Boc2O, H2, Pd/C; p) Tf2O, pyridine; q) KSAc; r) 0.2 N NaOH, 
MeI; s) trifluoroacetic acid (TFA)/CH2Cl2, 0°C. The reaction scheme was adapted 






The sulfur analog of the compound was not synthesized in order to avoid the odiferous 
synthetic reagents and compounds containing sulfur, and in consideration that a simplified 
synthetic scheme had not been established. The synthetic routes to the oxo derivative of the 
fluorinated methionine analog, 3,3-difluoro-L-methionine (4.25) are presented. The oxo 
derivative of methionine was hypothesized to act as a suitable substrate for the enzyme; and 
therefore, O-methyl-L-homoserine (4.22) was examined as a potential substrate for TvMGL1. 
Future studies of the proposed fluorinated compound may extend into characterizing the 
catalytic role of C113 in TvMGL1 as well as an investigation of its incorporation into 












4.7. Results and Discussion 
4.7.1. Synthetic Approaches to 3,3-Difluoro-L-Methionine Analogs 
The potential inhibitor, 3,3-difluoro-O-methyl- L-homoserine is expected to bind within 
the active site of TvMGL1. The methoxy group is not expected to interfere with the binding 
of the substrate since PpMGL and Citrobacter freundii (Cf)MGL are reported to process O-
ester-containing L-homoserine substrates (such as acetyl and succinyl moieties) (Esaki et al., 
1985; Manukhov et al., 2006). On the other hand, Lockwood and Coombs (1991) report that 
L-homoserine breakdown is not catalyzed by TvMGL and in fact acts as a weak inhibitor. 
Introducing a 3,3-difluoro moiety into the amino acid should not significantly impair binding 
of the suicide inhibitor, since a wide variety of fold type I family of PLP-dependent enzymes 
are capable of activating such compounds, as reported for 3,3,3-trifluoroalanine and 3,3-
dichloroalanine suicide inhibitors (Silverman and Abeles, 1975). Thus, the processing of this 
3,3-difluoro-O-methyl-L-homoserine by TvMGL1 has not been investigated, nor is it known 
whether the compound would be accepted as a substrate. 
O-Methyl-L-homoserine (OMHser) was used as a model substrate for TvMGL in order to 
test the possibility that the methoxy moiety of 3,3-difluoro-O-methyl-L-homoserine may be 
accommodated in the active-site of TvMGL1. The results indicated that the substrate 
specificity of the enzyme for O-methyl-L-homoserine is greater than L-methionine; a 3.5 fold 
increase in turnover rate (and no significant differences in Km values when compared to L-
methionine). Thus, the compound was turned over more rapidly than L-methionine, even 
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though the methoxide group of the compound should act as a poorer leaving group relative to 
the methanethiolate group of L-methionine during the γ-elimination step. Enhanced 
orientation of O-methyl-L-homoserine within the active site of the enzyme may have 
contributed to the faster turnover rate when compared to L-methionine, as a result of 
differences in hydrogen bonding acceptor strength and angle of the hydrogen bonding 
acceptor to donor molecule. Evidence to support this hypothesis is based on theoretical 
calculations at the B3LYP level of theory, where the sulfur atom of dimethyl sulfide-water 
complex, compared to the dimethyl ether equivalent, is reported to be a weaker hydrogen 
bonding acceptor as a result of its intermediate electronegativity and have a reduced O-H-X 
bond angle (where X = sulfur or oxygen) (Rablen et al., 1998). 
 
Table 4.1. The kinetic parameters of TvMGL1 for L-methionine and O-methyl-L-
homoserine (OMHSer). 
The standard errors were obtained from three independent experiments. 
 
The initial synthetic route to synthesize 3,3-difluoro-O-methyl- L-homoserine (4.25) was 
proposed as follows: 1) methyoxyacetyl chloride (4.26) condenses with 1,2-dimethyl 
imidazole to form an activated acyl ammonium intermediate (4.27), 2) Ti-crossed-Claisen 
condensation of the activated acyl ammonium intermediate (4.27) with a protected glycine 
Substrate Km kcat kcat/Km 
 mM min-1 M-1 s-1 
Methionine 0.22 ± 0.05 416 ± 15 32 x103 
OMHSer 0.44 ± 0.11 1470 ± 119 56 x103 
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(4.28) to yield the α-amido-β-ketoester 4.29, 3) fluorination of α-amido-β-ketoester 4.29 with 
DAST to afford 3,3-difluoro-O-methyl-D,L-homoserine (4.30), 4) saponification of the ester 
group, and 5) enzymatic resolution of the L-enantiomer with pig liver acylase (Figure 4.10). 
Precedent for the first reaction was recently described by Misaki et al. (2005), where a 
variety of β-ketoesters and α-amido-β-ketoesters are reported to be synthesized, including the 




Figure 4.10. Proposed synthetic route to 3,3-difluoro-O-methyl-L-homoserine 
(4.23). 
a) 1,2-Dimethyl imidazole, methylene chloride, 10 min, -45°C; b) titanium 
tetrachloride, triethylamine, methylene chloride, -45°C, 30 min; c) DAST, methylene 
chloride, -78°C to 21°C, 2 hr; d) 1.1 equiv. NaOH, 4°C, 30 min; e) porcine kidney 









amido-β-ketoesters with DAST has not been reported in the literature. Pig liver acylase has 
been previously utilized to resolve racemic mixtures of D, L-amino acids by hydrolyzing the 
acyl group from L-amino acids (Jones et al., 1991). 
Several attempts at the Ti-crossed-Claisen condensation reaction afforded the crude α-
amido-β-ketoester 4.29 with an estimated yield between 5 to 20%. Variations in the synthesis 
included the use of tributylamine as a base for the deprotonation of the α-carbon atom, 
anhydrous triethylamine, sequential addition of TiCl4 and triethylamine, and extraction of 
product with ethyl acetate. Due to the limited success of the reaction as a result of complexity 
in purification and low yields, an alternative synthetic route was examined. 
The condensation reaction with lithium diisopropylamide was employed to synthesize the 
α-amido-β-ketoester 4.35, in order to reduce the complexity of the synthesis (Figure 4.11), 
and since the procedure was successful in synthesizing a previously reported compound 
(4.32) (Nicolaou et al., 2008). Upon following the procedure, the methoxyacetyl chloride 
was found to react with the nitrogen of the N-acetylamido group of the protected glycine to 
afford compound 4.33, as opposed to the α-carbanion in order to afford compound 4.32 
(Figure 4.11). After several attempts at manipulating the reaction conditions, another 
synthetic step was pursued. 
The synthesis of an α-amido-β-ketoester, 2-N-acetylamido-3-oxo-ethylbutanoate (4.35a) is 
reported by Thrift et al. (1967) in a one pot reaction, which involves the oximination of the 
β-ketoester 4.34a at the α-carbon and subsequent reduction with zinc in acetic anhydride 
(Figure 4.11 d and e respectively). The reaction was found to be facile and the product was 
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easily purified by column chromatography with an overall yield of 40% and 60% for the α-







Figure 4.11. Synthetic routes toward α-amido-β-ketoester. 
Lithium diisopropylamide (LDA) condensation reaction (top): a) 2.5 equiv. LDA, 
THF, -70°C, 1 hr; b) 1.2 equiv. methoxyacetyl chloride, -70°C to 21°C, 15 min; c) 1.2 
equiv. dilute acetic acid, 4°C. Oximination of β-ketoester 4.34 (bottom): d) 1.1 equiv. 
sodium nitrite, acetate, 10°C to 21°C and e) 3 equiv. acetic anhydride, 3 equiv. zinc 
dust, 21 C, 1.5 hr. 
4.32 4.33 4.31 
4.35 a 
4.35 b 
4.34a: R1 = Et, R2 = Me 
4.34b: R1 = Me, 
           R2 = CH2OCH3 
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To synthesize the 3,3-difluoro compound from the α-amido-β-ketoester, DAST and 
Xtalfluor-E fluorination reagents were utilized under a variety of experimental conditions. 
Initial attempts with one equivalent of fluorinating reagent led to very little or no product, 
while two equivalents of the fluorinating reagent led to a complex mixture that decomposed 
upon purification. Based on the 1H-NMR spectrum for a partially purified product, 
compound 4.40 was produced from the α-amido-β-ketoester 4.35a starting material (Figure 
4.12). To validate the observation, two equivalents of DAST were tested on the β-ketoester 
4.34a starting material (Figure 4.12). The reaction afforded compound 4.39 based on 1H-
NMR and 19F-NMR, and is consistent with previous reports (Asato and Liu, 1986; Bildstein 
et al., 1995), despite several fractions that underwent decomposition upon purification on a 
silica gel column, (Figure 4.12). Alterations to the reaction conditions were also examined; 
however, the reaction did not afford the 3,3-difluoro compound of interest (see materials and 
methods). Thus, a lack of a reported procedure for fluorinating β-ketoesters with DAST may 
indicate that the tautomerization between the enol and keto forms of β-ketoester (Figure 








Figure 4.12. Side products reported for the deoxyfluorination of β-ketoesters. 
a) The enol and keto tautomers of a β-ketoester. Fluorination of the β-ketoester 4.34a 
with b) one equivalence of DAST affords α-fluoro- β-ketoester 4.36, and c) the 
second equivalence of DAST affords compound 4.37 and difluoro-olefine 4.38, e) 
extraction from brine affords compound 4.39 (Bildstein et al., 1995). f) α-amido-β-







Problems when fluorinating β-ketoesters with DAST have also been reported by Bosch et 
al. (1996), which yields the undesired side product similar to compound 4.39 reported here. 
To avoid this problem, the carbonyl group of the β-ketoester 4.35c is replaced with 1,2-
ethanedithiol to afford the dithiolane 4.41c, and then treated in a mixture containing pyridine 
hydrogen fluoride and N-bromosuccinimide (NBS) to afford the 3,3-difluoro-ester 4.42c 
(Figure 4.13) (Bosch et al., 1996). We also followed this synthetic route, in which the first 
step afforded 1,3-dithiolane in 95% yield from the β-ketoester 4.35d starting material. In the 
second step, the fluorination procedure resulted in several fluorinated side products with 
inconsistent results as indicated by 19F-NMR analysis. Synthesizing the dithiolane 4.41b with 
α-amido-β-ketoester 4.35b as the starting material was more problematic due to poor yields 
and problems resolving the compound by silica gel chromatography. In the second step, 
fluorination of the crude dithiolane 4.41b did not afford a fluorinated product as indicated by 
19F-NMR spectroscopy. Thus, the reaction was abandoned because the methoxy group in 
compound 4.35b was likely incompatible with the Lewis acid reagent used in the dithioketal 
protection and fluorination procedures, and this limitation has been previously reported by 







Figure 4.13. Synthesis of 3,3-difluoro-ester (4.43) from 1,3-dithiolane (4.41). 
Synthesis of 3,3-difluoro-ester (4.43): a) 1.5 equiv. boron trifluoride etherate, 
methylene chloride, 21°C, 24 hr; b) 2 equiv. N-bromosuccinimide, 20 equiv. 
pyridinium hydrofluoride, methylene chloride, -78°C, 30 min. 
 
An alternative synthetic route to 3,3-difluoro-D, L-amino acids is reported by the ring 
opening of azirines (4.46) with pyridinium hydrogen fluoride (Figure 4.14d), in synthesis of 
compounds such as 3,3-difluoro-2-D,L-amino-butanoate (4.47) (Wade and Kheribet, 1980). 
To synthesize the azirine ring 4.46, the starting material, β-ketoester 4.34 undergoes 
oximination to produce the ketoxime 4.43, which is immediately protected with a tosylate 
group to afford the oxime tosylate 4.45  in order to avoid the competing formation of 
isoxazolone (4.44; Figure 4.14) (Verstappen et al., 1996). The desired azirine 4.46 is 
synthesized by treating the oxime tosylate 4.45 with a base, such as triethylamine (Figure 
4.14c). Our first attempt at synthesizing the oxime tosylate 4.45a worked well (undertaken 
by a Chem 494 student, Qasim Bhatti), but synthesis of the azirine 4.46 compound was likel  
 
4.35b: R1 = Me, R2 = NH(CO)CH3, 
           R3 = CH2OCH3 
4.35c: R1 = H, R2 = H, R3 = Alkyl 


























































































Figure 4.14. Synthesis of 3,3-difluoro-L-amino acid (4.48) via the Neber reaction. 
a) 1.1 equiv. hydroxylamine-HCl, 1.1 equiv. sodium hydroxide, methanol, 22°C, 30 
min; b) 1.1 equiv. p-toluenesulfonyl chloride, methylene chloride, pyridine, 22°C, 3 
hr; c) 1.1 equiv. triethylamine, toluene, 4°C to 21°C, 24 hr; d) neat pyridinium 
hydrofluoride, benzene, 5°C, 10 min; e) lipase, water, 40°C, 24 hr. Adapted from 
Bosch et al. (1996), Verstappen et al. (1996), and Wade and Kheribet (1980). f) 1.1 
equiv. hydroxylamine-HCl, 1.1 equiv. sodium hydroxide, methanol or water, 22°C, 30 
min; g) 1.1 equiv. p-toluenesulfonyl chloride, methylene chloride, pyridine, 21°C, 3 
hr. 
4.45a 4.46 








lost upon removal of solvent in vacuo. On the other hand, oximination of the starting material 
4.34b (the methoxy derivative) afforded the undesired the isoxazolone tosylate 4.49 side 
product, instead of a protected the oxime tosylate 4.45b. Similar problems have been 
reported by Sakai et al. (2005) and Alves et al. (2005), and in one case is alleviated by 
utilizing a t-butyl ester protecting group. Substituting methanol with water (step f) afforded 
the oxime tosylate 4.45b in low yields (Figure 4.14). Thus, synthesis of the was problematic 
because of intramolecular cyclization of β-oximinoester 4.43b to afford the undesired 
isoxazolone tosylate 4.49. Methods to reduce the intramolecular cyclization of the oxime 
might require maintaining the temperature of the water bath below 40°C when removing 
methanol in vacuo, or by introducing a t-butyl ester protecting group into the compound. 
 
4.8. Conclusions and Future Work 
The methoxy moiety for the proposed compound 3,3-difluoro-O-methyl-L-homoserine is 
expected to bind to TvMGL1, considering that the enzyme is able to catalyze the 
electronegative substituent of O-methyl L-homoserine with a 3.5-fold greater turnover rate 
than L-methionine and with no significant differences in Km values. Work by Silverman and 
Ables suggests that orthologous PLP-dependent MGLs, such as cystathione-γ-lyase and 
cystathionine-γ-synthase, are capable of accommodating fluorine substitutions at the Cβ atom 
of L-amino acids, and consequently result in the inhibition of the enzyme (Silverman and 
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Abeles, 1976). Therefore, the fluorine atoms in the proposed compound, 3,3-difluoro-O-
methyl-L-homoserine should inhibit the activity of TvMGL1. 
The underlying reason(s) for TvMGL1 exhibiting a greater substrate specificity for O-
methyl L-homoserine than L-methionine is unknown. One possible explanation is an 
improved orientation of the compound within the active site when compared to L-methionine. 
Thus, future biophysical and structural data are required in order to investigate this 
possibility. 
A general synthetic strategy for synthesizing 3,3-difluoro-O-methyl-L-homoserine has yet 
to be determined. Fluorination of β-ketoesters was unsuccessful when utilizing DAST and 
similar fluorinating reagents reported in this study, which led to a side product (4.39) that is 
consistent with literature reports (Asato and Liu, 1986; Bildstein et al., 1995; Bosch et al., 
1996). The use of a dithiolane protecting group and a Lewis acid to fluorinate the Cβ atom 
did not appear to be feasible for the β-ketoester 4.35b starting material because the methoxy 
moiety might be labile to nucleophilic attack as reported for the synthesis of (±)-Cherylline 
(Hart et al., 1978b). The most promising synthetic route was the Neber reaction, which has 
been successfully applied in the synthesis of 3,3-difluoro phenylalanine and 3,3-difluoro-2-
aminobutyric acid (Verstappen et al., 1996; Wade and Kheribet, 1980). However, upon 
following the procedures, the undesired isoxazolone side product was obtained, which is 
consistent with reports from two independent groups (Alves et al., 2005; Sakai et al., 2005). 
The Neber reaction is a likely route to synthesizing 3,3-difluoro-O-methyl-L-homoserine; 
however, a strategy to prevent the undesired isoxazolone side product will have to be 
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addressed. Thus, the potential inhibitor, 3,3-difluoro-O-methyl-L-homoserine has yet to be 
synthesized and tested on TvMGL1. 
 
4.9. Materials and Methods 
4.9.1. General Experimental 
Anhydrous solvents and reagents were obtained by standing over a drying reagent (15 to 24 
hr) as previously reported (Burfield and Smithers, 1978). The appropriate drying reagent for 
removing trace water from the solvents was selected based on drying agent compatibility 
charts (Merck KGaA, Darmstadt, Germany). Briefly, ethyl acetate was dried over anhydrous 
KHCO3, and alkylamines (triethylamine, tributylamine and pyridine) were dried over 
potassium hydroxide. The following anhydrous solvents and reagents in Sure-Seal protected 
containers were obtained from Aldrich Chemicals (Milwaukee, WI): methylene chloride, 
THF, neat TiCl4, methoxyacetyl chloride, lithium diisopropylamide in THF. For water 
sensitive reactions, all glassware and syringes were dried in a 110°C oven before use and 
assembled under an argon atmosphere while supplying heat by way of using a heating gun. 
During workup, drying of organic solutions was accomplished over anhydrous sodium 
sulfate or anhydrous magnesium sulfate. 
Reagent grade solvents were used throughout the experiments and were purchased from 
Aldrich Chemicals unless otherwise stated. 
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Solvent evaporation was carried out under reduced pressure (Wheaton water aspirator) 
with a bath temperature of 20 to 40°C. 
Thin layer chromatography was carried out on aluminum-backed sheets, precoated with 
Kieselgel 60 F254, 0.2 m thick (EMD Chemicals Inc., Darmstadt, Germany). Prepacked flash 
silica gel chromatography columns were obtained commercially (Biotage; Charlotte, NC), 
and samples were purified utilizing Isolera One Flash Purification System (Biotage). 
NMR spectra were recorded on a Bruker 300 MHz NMR, operating at 300.13 MHz for 1H-
NMR and 282.40 Hz for 19F-NMR. The chemical shifts (δ ppm) for 1H-NMR were reported 
downfield from the internal reference standard TMS (0 ppm). The chemical shifts (δ ppm) 
for 19F NMR were recorded upfield from the external reference standard trifluoroacetic acid 
(-76.53 ppm). Mass spectra were recorded using electrospray ionization (ESI), electron 
ionization (EI) or chemical ionization (CI; NH3 as the reactant gas), which were obtained by 
Dr. R. W. Smith (University of Waterloo, Waterloo, ON). 
 
4.9.2. MBTH Assay Method for Detecting α-Ketobutyrate 
The activity of MGL was monitored by utilizing the MBTH assay as previously described 
(Soda, 1968). Briefly, the 50 μL reaction mixture for the turnover of L-methionine consisted 
of 60 mM HEPES-NaOH, pH 8.0, 10 μM PLP, 0.05 to 3.0 mM substrate, and 0.1 μM 
TvMGL1. The reaction mixture for the turnover of O-methyl-L-homoserine was the same as 
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above except 0.5 to 4 mM substrate and 0.05 μM TvMGL1 were used. All other procedures 
were followed as described in section 2.6.7. 
 
4.9.3. O-Methyl-L-Homoserine Physical Data 
O-Methyl-L-homoserine was purchased from CBL (Patras, Greece), purity not available. 
White solid: decomp. 224°C (lit. 224-225°C) (McCoy et al., 1935). 
1H-NMR (D2O) δ: 2.16 (m, 2H, CβH2), 3.38 (s, 3H, OCH3), 3.69 (m, 2H, CγH2), 3.87 (dd, 
1H, CαHA, Jab = 4.3 Hz, Jbx = 7.2 Hz). Lit. 
1H-NMR (D2O): 2.02-2.26 (m, 2H), 3.36 (s, 3H); 
3.57-3.79 (m, 2H); 3.85 (dd, 1H, J = 7.4 Hz) (Seebach et al., 1987). ESI-MS calculated for 
C5H12NO3
+ (M+H)+ 134.08176, found 134.0727.  
 
4.9.4. Titanium-Claisen Condensation Reaction 
The synthesis was adapted from Misaki et al. (2005) and Carlson et al. (1992). The reaction 
was contained in a three-neck 25 mL round bottom flask, a water-cooled condenser, under 
argon, and a magnetic stirring bar was added. Methoxy acetyl chloride (1.50 mmol, 137 μL) 
was added dropwise over 10 min to a solution of 1,2 dimethyl imidazole (1.50 mmol, 150 
mg) in methylene chloride (2 mL) at -45°C. Within 10 min of stirring, a white precipitate 
formed, and the mixture was purged with argon gas. Ethyl acetamidoacetate (1.00 mmol, 145 
mg) and neat TiCl4 (3.00 mmol, 330 μL) were sequentially added to the mixture and stirred 
for 10 min at -45°C, which completely dissolved the white precipitate and resulted in a 
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yellow homogenous solution. Anhydrous Et3N (3.30 mmol, 460 μL) was added dropwise to 
the mixture (resulting in the solution turning dark red and then black), and warmed up to 4°C 
for 30 min. The mixture was cooled with ice, then quenched with brine (10 mL) and aqueous 
NaHCO3 (8.4 mmol, 0.71 g). The product was extracted with ethyl acetate (3 x 25 mL), dried 
with sodium sulphate, and concentrated in vacuo to yield a colourless oil. Attempts to purify 
the crude product by silica column chromatography or oiling out the product with methylene 
chloride/hexane were unsuccessful. 
Crude α-amido-β-ketoester 4.28 product in 10 to 20% yield. Rf (ethyl acetate/THF, 2:1) 0.5. 
1H-NMR data not available. EI-MS calculated for C9H16NO5
+ [M+H]+ 218.10288, found 
218.12. 
 
4.9.5. Neber Reaction 
4.9.5.1. Synthesis of Tosylates 
The procedure was adapted from Wade (1980) and Vestappen (1996). 4-Methoxy methyl 
acetoacetate (compound 4.34b; 2.00 mmol, 258 μL) was added to a solution containing 
hydroxylamine-HCl (2.10 mmol, 153 mg) and NaOH (2.1 mmol, 88 mg) in aqueous 
methanol (10 mL) 22°C. After 30 min the solvent was removed under reduced pressure 
(temperature 40°C), and extracted with ethyl acetate (2 x 10 mL). The combined organic 
fractions were dried with anhydrous magnesium sulphate, and concentrated in vacuo. The 
crude oxime was immediately dissolved in dry dichloromethane (15 mL), and p-
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toluenesulfonyl chloride (2.00 mmol, 381 mg dissolved in 1 mL CH2Cl2) and pyridine (2.00 
mmol, 161 μL) were added sequentially at 22°C. The reaction was stirred for 3 hr, quenched 
with saturated aqueous ammonium chloride solution (10 mL), and extracted with ethyl 
acetate (3 x 10 mL). The combined organic layers were washed with brine (2 x 10 mL) and 
dried over magnesium sulphate. The major product, isoxazolone was purified by slica gel 
flash chromatography and concentrated in vacuo. The oxime tosylate 4.45a was synthesized 
in a similar manner, but with ethyl acetoacetate (compound 4.34a; 2.00 mmol, 225 μL) as a 
starting material, and the product was resolved by silica gel flash chromatography. 
The isoxazolone tosylate 4.49 was isolated as an oil (184 mg, 70%). Rf (hexane/ethyl acetate, 
7:1) 0.17. 1H-NMR (CDCl3) δ: 2.48 (s, 3H, CH3), 3.37 (s, 3H, CH3), 4.42 (s, 2H, CH2), (s, 
1H, CαH2), 5.93 (s, 1H, CH1), 7.39 (d, 2H, aromatic, J = 8.3 Hz), 7.85 (d, 2H, aromatic, J = 
8.3 Hz). ESI-MS calculated C12H14NO5S
+ [M+H]+ 284.05932, observed 284.0415. 
The oxime tosylate 4.45a was isolated as a yellow oil (479 mg, 80%). Rf (hexane/ethyl 
acetate, 4:1) 0.75. 1H-NMR (CDCl3) mixture of isomers δ: 1.24 (m, 3H, CH2CH3), 2.04 (d, 
3H, CγH3, J = 4.9 Hz), 2.44 (s, 3H, ArCH3), isomer 3.25 (s, 1H, CαH2), isomer 3.43 (s, 1H, 
CαH2), 4.14 (m, 2H, COCH2), 7.33 (d, 2H, aromatic H, J = 8.3 Hz), 7.85 (d, 2H, aromatic H, 
J = 8.3 Hz). ESI-MS not available. 
Aqueous NaOH (2.1 mmol, 88 mg, in 1 mL H2O) was added to 4-methoxy methyl 
acetoacetate (compound 4.34b; 2.00 mmol, 258 μL, in 3 mL H2O) at 22°C. After 30 min the 
solvent was removed under reduced pressure (temperature 30°C), and extracted with CH2Cl2 
(3 x 5 mL). The combined organic fractions were dried with anhydrous magnesium sulphate. 
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The crude oxime was immediately added to p-toluenesulfonyl chloride (2.00 mmol, 381 mg 
dissolved in 1 mL CH2Cl2), followed by the addition pyridine (2.00 mmol, 161 μL) at 22°C. 
The reaction was stirred for 3 hr, quenched with saturated aqueous ammonium chloride 
solution (10 mL), and extracted with ethyl acetate (3 x 10 mL). The combined organic layers 
were washed with brine (2 x 10 mL) and dried over magnesium sulphate. The crude product, 
tosyl oxime was purified by slica gel flash chromatography and concentrated in vacuo. 
Oxime sulfonate 4.45b was isolated as a light yellow oil (32 mg, 5%). Rf (CHCl3/CH2Cl2, 
3:1) 0.14. 1H-NMR (CDCl3) δ: 2.45 (s, 3H, ArCH3), 3.31 (s, 3H, CH3), 3.34 (s, 2H, CH2), 
3.67 (s, 3H, CH3), 4.33 (s, 2H, CH2), 7.34 (d, 2H, aromatic H, J = 8.1 Hz), 7.84 (d, 2H, 
aromatic H, J = 8.1 Hz). ESI-MS not available. 
 
4.9.5.2. Synthesis of Azirine Ester 
The oxime tosylate 4.45a (2.00 mmol, 470 mg) was added dropwise (over a period of 15 
min) to a stirred solution containing dry toluene (15 mL) and Et3N (2.00 mmol, 279 μL) at 
0°C. After stirring the reaction for 24 hr, it was quenched with aqueous HCl (50.0 mM, 110 
mL), and the compound was extracted with diethyl ether (3 x 20 mL). The combined organic 
layers were washed with brine, dried over anhydrous magnesium sulphate and concentrated 
in vacuo, but the crude (±) azirine ester 4.46 was likely lost during this process. 1H-NMR 
(CDCl3) mixture of isomers δ: 1.28 (t, 3H, CH2CH3, J = 7.1 Hz), isomer 2.45 (s, 2.6H, 




4.9.6. Lithium Diisopropylamide-cross Claisen Condensation Reaction 
The procedure was adapted from Nicolaou et al. (2008). Lithium diisopropylamide (3.45 
mmol, 2.30 mL) was added to tetrahydrofuran (5 mL) at -78°C under argon. t-Butyl 
acetoamidoacetate (compound 4.31; 1.38 mmol, 204 μL diluted in 1 mL of anhydrous THF) 
was added drop wise over a period of 15 min, and the solution was stirred vigorously for 1 
hr. (Incubation time for lithium diisopropylamide may require more time and higher 
temperature in order to deprotonated the α-carbon atom). Methoxyacetyl chloride (1.65 
mmol, 151 μL) was added to the mixture dropwise over a period of 15 min, which led to the 
appearance of white precipitate. The temperature was maintained at -78°C for 1 hr, and 
afterwards warmed up to 22°C for 15 hr. The reaction was quenched with acetic acid (5.00 
mmol, 286 μL) and brine (5 mL) at -10°C. The aqueous solution was extracted with diethyl 
ether (3 x 25 mL), and the organic layers were combined and dried with anhydrous sodium 
sulphate. Sample was resolved on a silica gel column by flash chromatography. 
Compound 4.33 was isolated as an oil (210 mg, 60%). Rf (hexane/ethyl acetate, 2:1) 0.5. 
1H-
NMR (CDCl3) δ: 1.51 (s, 9H, C(CH3)3, 3.47 (s, 3H, CH3), 3.74 (s, 3H, CH3), 4.47 (s, 2H, 
CH2), 4.60 (s, 2H, CH2). MS-ESI data not available. 
 
4.9.7. Oximination of β-Ketoesters 
Synthetic procedures were adapted from Nudelman and Nudelman (1999) and Girard et al. 
(1996). In a round bottom flask, β-ketoester (10.3 mmol; 1.33 mL of compound 4.34a; 2.63 
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mL of compound 4.34b) was dissolved in acetic acid (4 mL). NaNO2 (11.0 mmol, 770 mg) 
was added over a period of 20 min, and the temperature of the exothermic reaction was 
maintained below 12°C in an ice-water bath. The mixture was warmed up to 22°C and 
proceeded for 3.5 hr with stirring, and the solution changed from yellow to an orange colour. 
Acetic anhydride (30.0 mmol, 2.82 mL) was added to the mixture, followed by zinc powder 
(30.0 mmol, 1.96 g) over a period of 1 hr. The mixture was topped up by the addition of 
acetic acid (3 mL) in order to dissolve any crystals formed, and stirred for a total of 2 hr at 
22°C. The mixture was filtered and the cake was washed with ethyl acetate (60 mL). Samples 
were dried in vacuo and purified on a silica column by flash chromatography. 
α-Amido-β-ketoester 4.35a was isolated as a colourless oil (1.16 g, 60%). Rf (hexane/ethyl 
acetate, 2:1) 0.22. 1H-NMR (CDCl3) δ: 1.30 (t, 3H, CH2CH3, J = 7.2 Hz), 2.06 (d, 3H, CH3, J 
= 4.9 Hz), 2.38 (s, 3H, CγH3), 4.27 (t, 2H, OCH2CH3, J = 7.2 Hz), 5.24 (d, 1H, CαH, J = 7.2 
Hz). ESI-MS calculated for C8H14NO4
+ [M+H]+ 188.09232, found 188.0845. 
α-Amido-β-ketoester 4.35b was isolated as a colourless oil (837 mg, 40%). Rf (methylene 
chloride/ethyl acetate, 2:1) 0.22. 1H-NMR (CDCl3) δ: 2.07 (s, 3H, CH3), δ: 3.45 (s, 3H, 
OCH3), δ: 4.36 (d, 2H, CH2, J = 6.1 Hz), δ: 5.40 (d, 1H, CαH, J = 6.6 Hz). ESI-MS calculated 
for C8H14NO5




4.9.8. Fluorination of β-Ketoesters with Tetrafluoride Analog Reagents 
4.9.8.1. Diethylaminosulfur Trifluoride Reagent 
A solution of β-ketoester (0.53 mmol; either 67 μL compound 4.34a, 99 mg compound 
4.35a, or 108 mg compound 4.35b) in methylene chloride (2 mL) contained in a three-neck, 
25 mL round bottom flask, under argon, a rubber septum and magnetic stirring bar was 
cooled to -78°C. Neat DAST (1.06 mmol, 140 μL) was added to the solution dropwise over a 
period of 15 min, and warmed up to 21°C for 2 hr. The reaction was quenched with NaHCO3 
(2.5 mL). The products were extracted with methylene chloride (3 x 2 mL), the organic phase 
was dried with sodium sulphate, filtered and evaporated in vacuo, and purified on a silica 
column by flash chromatography. Alternative variations to the reaction include addition of 
either ZnI2 (0.50% mmol, 1.6 mg), BF3 diethyletherate (2.12 mmol, 2.7 mL; 1.1 mmol, 1.3 
mL; or 0.69 mmol, 0.87 mL), or triethylamine trihydrofluoride (1.20 mmol, 195 μL; or 0.60 
mmol, 98 μL) before the addition of DAST. No products were observed when using 1:1 ratio 
of starting material and DAST as indicated by 1H-NMR spectroscopy. 
Compound 4.39 was isolated as a colourless oil (24 mg, 15%). Rf (hexane/ethyl acetate, 
10:1) 0.51. 1H-NMR (CDCl3) δ: 1.11 (t, 6H, (CH2CH3)2, J = 7.3 Hz), 1.33 (t, 3H, CH2CH3, J 
= 7.3 Hz), δ: 2.39 (d, 3H, CγH3, J = 3.9 Hz), δ: 3.04 (q, 4H, (CH2CH3)2, J = 6.9 Hz), δ: 4.29 
(m, 2H, CH3CH2). 
19F NMR (CDCl3; externally locked with CFCl3) δ: -143 (s). No mass 




4.9.8.2. Reaction of XtalFluor-E Reagent with a Model β-Ketoester 
A solution of XtalFluor-E (0.0530 mmol, 12.1 mg; Sigma Aldrich) and triethylamine 
trihydrofluoride (0.11 mmol, 17 μL) in anhydrous methylene chloride (0.2 mL) were 
contained in a 3 mL conical vial with a water-cooled condenser, under argon, magnetic 
stirring bar, and cooled to -78°C. The model β-ketoester (0.0530 mmol, 11.5 mg dissolved in 
0.1 mL of anhydrous methylene chloride; 2-ethoxyamido-3-oxo-ethylbutyrate) was added 
dropwise to the mixture over a period of 10 min. The mixture was warmed up to 22°C and 
stirred for 2 hr. The reaction was quenched with NaHCO3 (1 mL), and the products were 
extracted into methylene chloride (3 x 1 mL), dried with sodium sulphate, filtered and 
evaporated in vacuo. The mixture had several side products based on TLC analysis, and no 
success was obtained by silica gel column chromatography.  
 
4.9.9. Dithiolane Esters 
4.9.9.1. Synthesis of Dithiolane Ester 
A solution of β-ketoester (0.53 mmol; either 67 μL compound 4.35d or 108 mg compound 
4.35b) and 1,2 ethanedithiol (1.06 mmol 124 μL) in anhydrous methylene chloride (2 mL) 
were contained in a three-neck, 25 mL round bottom flask, under argon, a rubber septum and 
magnetic stirring bar at 22°C. After 10 min, BF3-Et2O (0.689 mmol, 87.0 μL) was added 
dropwise to the mixture and stirred at 22°C for 15 hr. For dithiolane 4.41d afforded from β-
ketoester 4.35d starting material, the mixture was diluted with hexane (3 mL) and washed 
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with brine (3 x 3 mL). For dithiolane 4.41b afforded from β-ketoester 4.35b starting material, 
the mixture was diluted with ethyl acetate (3 mL) and washed with brine (3 x 3 mL). The 
organic extracts were dried with sodium sulphate, concentrated in vacuo as colourless oils, 
and purified by flash silica gel chromatography. 
1,2-Dithiolane-3-ethylbutanoate (4.41d) was isolated as a colourless oil (104 mg, 95%). Rf 
(hexane/ethyl acetate, 7:1) 0.57. 1H-NMR (CDCl3) δ: 1.25 (t, 3H, CH2CH3, J = 7.1 Hz), 1.89 
(s, 3H, CH3), δ: 2.99 (s, 2H, CH2), δ: 3.32 (s, 4H, CH2CH2), δ: 4.14 (q, 2H, CH2CH3, J = 7.1 
Hz). No mass detected by ESI-MS and ESI-GC/MS for the expected [M++H]+ product. 
The complex reaction mixture for 1,2-dithiolane-3-methoxy-3-methylbutanoate (4.41b) 
precluded its isolation by flash silica gel chromatography. ESI-MS calculated for 
C10H18NO4S2
+ [M+H]+ 280.06784, found 280.0550. 
 
4.9.9.2. Fluorination of 3,3-Dithioester 
A solution of N-bromosuccinimide (2.00 mmol, 362 mg) and pyridinium hydrofluoride (3 
mmol, 351 μL) in methylene chloride (2 mL) at -78°C with stirring were contained in a 25 
mL round bottom polypropylene flask, under argon, a rubber septum and magnetic stirring 
bar. Compound 4.41d (0.500 mmol, 105 mg) was added dropwise over 15 min and stirred for 
60 min at -78°C. The mixture was diluted with methylene chloride (10 mL). The bottom 
layer of the organic solution was applied to neutral alumina resin and the flow through was 




19F-NMR (externally locked with CFCl3) δ: -67.6, -73.4, -86.2, -90.7. No mass detected by 
ESI-MS and ESI-GC/MS for the expected [M++H]+ product. 
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CHAPTER 5  
SUMMARY AND FUTURE WORK 
 
The thioacylating agents generated from the processing of fluorinated methionine analogs by 
L-methionine γ-lyase from T. vaginalis (TvMGL1) were identified and their chemistry was 
characterized. Thiocarbonyl difluoride generated from the processing of TFM (5.1) by 
TvMGL1 was found to sequentially thiocarbamoylate two primary amines. On the other 
hand, thioformyl fluoride generated from the processing of DFM (5.2) by TvMGL1 was 
found to thioformylate a single primary amine, but had the potential to form an amidine upon 
reacting with a second primary amine. Based on theoretical calculations using high level of 
theory, the theoretical pKa values for the mercaptans, generated from the enzymatic 
processing of the fluorinated compounds by TvMGL1, suggests that the compounds are 
likely to collapse as a result of elimination. The theoretical calculated heats of formation for 
thiocarbomylation and thioformylation suggests that the reactions are extremely 
thermodynamically favourable. For model organisms expressing MGL, these results suggest 
that the generation of the thioacylating agents, upon processing the fluorinated methionine 
analogs by TvMGL1, likely contributed to the observed cellular cytotoxicity in the cell 
growth inhibition assay. Thus, the generation of the thioacylating agents likely results in 
cellular toxicity as a result of thioacylation of primary amines, and may not require cross-
linking as previously proposed by Alston and Bright (1983). Knowledge of the chemistry for 
the thioacylating agents may be applied to other areas of cellular biochemistry, and in 
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designing a second generation of fluorinated methionine analogs by replacing the hydrogen 









5.2 5.3: R = Alkyl 
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The enzymatic processing of TFM and DFM by TvMGL1 reveals that the γ-elimination 
step is rate determining. The bulky fluorine atoms in the compound were found to enhance 
the turnover rate of the enzyme, and did not interfere with the Michaelis-Menten complex. 
The results suggest that the enzyme may handle large side chain substitutions. Mutation of 
the active site residue, C113 in TvMGL1, suggests that the residue plays an important role in 
catalysis. A definitive understanding into the exact role of C113 side chain, such as its 
implicated role in substrate specificity, will require structural and biophysical data in order to 
substantiate the kinetic values, which has not been reported for MGL enzymes as studied to 
date. Future application of TvMGL1 C113S mutant may extend to verifying its catalytic role 
by using fluorinated methionine analogs. 
A synthetic route to 3,3-difluoro-O-methyl- L-homoserine (5.7), an oxo derivative of L-
methionine was not obtained. A promising route might involve the Neber reaction, if one is 
able to avoid the undesired side product, isoxazole. The only reported synthetic route to the 
sulfur derivative, 3,3-difluoro-L-methionine (5.5), involves 19 steps with an overall yield of 
0.4% (Keqiang et al., 1998). Thus, there is a need to find an alternative synthetic route to the 
oxo derivative, 3,3-difluoro-O-methyl- L-homoserine (5.7). Future studies with the 
fluorinated compound may involve characterization of the catalytic role of C113 in 
TvMGL1, and its incorporation into proteins as an unnatural amino acid for biophysical 
studies.  
Enzymatic processing of O-methyl-L-homoserine (5.6) by TvMGL1 is 3.5-fold greater 
than the turnover rate of L-methionine and no significant differences in its Km value when 
compared to L-methionine. The results suggest that the proposed oxo moiety in 3,3-difluoro-
O-methyl-L-homoserine (5.7) will not interfere with the processing of the compound. These 
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results are unexpected because the oxo moiety is a poorer leaving group than sulfur. Reasons 
for the enhanced turnover are unclear, but it may have resulted from an improved orientation 
within the active site of the enzyme. Thus, future biophysical and structural data are required 
to further elucidate these differences. 
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